Dynacq Healthcare (DYII) 10-K 21 Nov 13 2013 FY Annual report Financial data

Document_And_Entity_Informatio

Document And Entity Information (USD $)	12 Months Ended
	Aug. 31, 2013	Nov. 08, 2013	Feb. 28, 2013
Document Information [Line Items]	'	'	'
Entity Registrant Name	'DYNACQ HEALTHCARE INC	'	'
Entity Central Index Key	'0000890908	'	'
Current Fiscal Year End Date	'--08-31	'	'
Entity Filer Category	'Smaller Reporting Company	'	'
Trading Symbol	'DYII	'	'
Entity Common Stock, Shares Outstanding	'	14,418,626	'
Document Type	'10-K	'	'
Amendment Flag	'false	'	'
Document Period End Date	31-Aug-13	'	'
Document Fiscal Period Focus	'FY	'	'
Document Fiscal Year Focus	'2013	'	'
Entity Well-known Seasoned Issuer	'No	'	'
Entity Voluntary Filers	'No	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Public Float	'	'	$11,891

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Aug. 31, 2013	Aug. 31, 2012
Assets	'	'
Cash and cash equivalents	$13,585,447	$10,638,217
Accounts receivable, net of allowances of approximately $170,198,000 and $187,478,000	1,062,029	797,964
Inventories	293,565	408,961
Trading securities	1,071,346	1,280,518
Interest receivable	102,964	167,229
Prepaid expenses	180,883	423,659
Income tax receivable	569,430	569,430
Assets of discontinued operations	0	5,401,092
Total current assets	16,865,664	19,687,070
Investments available-for-sale	17,458,985	16,828,886
Investment in real estate, net	0	1,889,395
Property and equipment, net	6,323,657	6,655,820
Income tax receivable	800,920	868,249
Other assets	187,101	255,876
Total assets	41,636,327	46,185,296
Liabilities and stockholders’ equity	'	'
Accounts payable	1,012,328	2,271,436
Accrued liabilities	11,845,317	11,763,362
Current portion of notes payable	40,256	105,735
Current portion of capital lease obligations	115,737	101,696
Total current liabilities	13,013,638	14,242,229
Non-current liabilities:	'	'
Long-term portion of notes payable	6,744	1,074,187
Long-term portion of capital lease obligations	69,978	87,465
Total liabilities	13,090,360	15,403,881
Commitments and contingencies	'	'
Dynacq stockholders' equity:	'	'
Preferred stock, $.01 par value; 5,000,000 shares authorized, none issued or outstanding	0	0
Common stock, $.001 par value; 100,000,000 shares authorized, 14,543,626 shares issued and outstanding	14,544	14,544
Additional paid-in capital	10,282,256	10,172,794
Accumulated other comprehensive income	9,382,334	8,419,324
Retained earnings	8,803,410	12,108,494
Total Dynacq stockholders’ equity	28,482,544	30,715,156
Non-controlling interest	63,423	66,259
Total equity	28,545,967	30,781,415
Total liabilities and equity	$41,636,327	$46,185,296

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets [Parenthetical] (USD $)	Aug. 31, 2013	Aug. 31, 2012
Allowance For Doubtful Accounts Receivable Current	$170,198,000	$187,478,000
Preferred stock, par value	$0.01	$0.01
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	14,543,626	14,543,626
Common Stock, Shares, Outstanding	14,543,626	14,543,626

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (USD $)	12 Months Ended
	Aug. 31, 2013	Aug. 31, 2012
Net patient service revenue	$6,057,411	$5,531,233
Costs and expenses:	'	'
Compensation and benefits	5,514,147	7,176,781
Medical services and supplies	1,664,780	1,557,792
Other operating expenses	5,956,192	4,399,283
Depreciation and amortization	463,552	550,643
Total costs and expenses	13,598,671	13,684,499
Operating loss	-7,541,260	-8,153,266
Other income (expense):	'	'
Rent and other income	3,770,372	961,781
Interest income	872,624	1,225,910
Interest expense	-561,071	-590,395
Total other income, net	4,081,925	1,597,296
Loss before income taxes from continuing operations	-3,459,335	-6,555,970
Provision for income taxes	0	-4,018,699
Loss from continuing operations	-3,459,335	-10,574,669
Income (loss) from discontinued operations, net of income taxes	151,415	-1,624,185
Net loss	-3,307,920	-12,198,854
Less: Net loss attributable to noncontrolling interest	2,836	47,358
Net loss attributable to Dynacq Healthcare, Inc.	($3,305,084)	($12,151,496)
Basic and diluted earnings (loss) per common share:	'	'
Loss from continuing operations attributable to Dynacq Healthcare, Inc.	($0.24)	($0.73)
Income (loss) from discontinued operations, net of income taxes	$0.01	($0.12)
Net loss attributable to Dynacq Healthcare, Inc.	($0.23)	($0.85)
Basic and diluted average common shares outstanding	14,543,626	14,489,780

Consolidated_Statements_of_Com

Consolidated Statements of Comprehensive Income (Loss) (USD $)	12 Months Ended
	Aug. 31, 2013	Aug. 31, 2012
Net loss	($3,307,920)	($12,198,854)
Other comprehensive income, net of taxes:	'	'
Net change in foreign currency translation adjustment, net of taxes of $(4,414) and $(513,803)	-8,196	-944,586
Net change in fair value of available-for-sale securities, net of taxes of $-0- and $(3,500,481)	971,206	1,910,234
Other comprehensive income	963,010	965,648
Comprehensive loss	-2,344,910	-11,233,206
Less comprehensive loss attributable to noncontrolling interest	2,836	47,358
Comprehensive loss attributable to Dynacq Healthcare, Inc.	($2,342,074)	($11,185,848)

Consolidated_Statements_of_Com1

Consolidated Statements of Comprehensive Income (Loss) [Parenthetical] (USD $)	12 Months Ended
	Aug. 31, 2013	Aug. 31, 2012
Net change in foreign currency translation adjustment, net of taxes	($4,414)	($513,803)
Net change in fair value of available-for-sale securities, net of taxes	$0	($3,500,481)

Consolidated_Statements_of_Cha

Consolidated Statements of Changes in Equity (USD $)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Foreign currency translation [Member]	Unrealized gains (losses) on securities [Member]	Retained Earnings [Member]	Noncontrolling Interest [Member]
Balance at Aug. 31, 2011	$41,572,547	$14,427	$9,780,837	$952,782	$6,500,894	$24,259,990	$63,617
Balance, Shares at Aug. 31, 2011	'	14,426,960	'	'	'	'	'
Stock issued for non-controlling interest sale and employee compensation	116,666	117	116,549	0	0	0	0
Stock issued for non-controlling interest sale and employee compensation (shares)	'	116,666	'	'	'	'	'
Stock based compensation	275,408	0	275,408	0	0	0	0
Capital contribution	50,000	'	'	'	'	'	50,000
Reclassification adjustment for foreign currency gains included in net income, net of taxes	-921,318	0	'	-921,318	0	0	0
Foreign currency translation adjustment, net of taxes of $(12,530)	-23,268	0	0	-23,268	0	0	0
Unrealized gains on securities available-for-sale, net of taxes	1,910,234	0	0	0	1,910,234	0	0
Net loss	-12,198,854	0	0	0	0	-12,151,496	-47,358
Balance at Aug. 31, 2012	30,781,415	14,544	10,172,794	8,196	8,411,128	12,108,494	66,259
Balance, Shares at Aug. 31, 2012	'	14,543,626	'	'	'	'	'
Stock based compensation	109,462	0	109,462	0	0	0	0
Reclassification adjustment for foreign currency gains included in net income, net of taxes	-8,196	0	'	-8,196	0	0	0
Reclassification adjustment for gain on call of securities, available-for-sale, net of taxes of $-0-	-2,199,500	0	0	0	-2,199,500	0	0
Foreign currency translation adjustment, net of taxes of $(12,530)	0	'	'	'	'	'	'
Unrealized gains on securities available-for-sale, net of taxes	3,170,706	0	0	0	3,170,706	0	0
Net loss	-3,307,920	0	0	0	0	-3,305,084	-2,836
Balance at Aug. 31, 2013	$28,545,967	$14,544	$10,282,256	$0	$9,382,334	$8,803,410	$63,423
Balance, Shares at Aug. 31, 2013	'	14,543,626	'	'	'	'	'

Consolidated_Statements_of_Cha1

Consolidated Statements of Changes in Equity [Parenthetical] (USD $)	12 Months Ended
	Aug. 31, 2013	Aug. 31, 2012
Foreign currency translation adjustment, taxes	$0	($12,530)
Reclassification adjustment for foreign currency gains included in net income, taxes	-4,414	-501,273
Unrealized gains (loss) on securities available-for-sale, taxes	$0	($3,500,481)

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	12 Months Ended
	Aug. 31, 2013	Aug. 31, 2012
Cash flows from operating activities	'	'
Net loss	($3,307,920)	($12,198,854)
Less (income) loss from discontinued operations, net of income taxes	-151,415	1,624,185
Net loss before discontinued operations	-3,459,335	-10,574,669
Adjustments to reconcile net loss before discontinued operations to net cash from operating activities:	'	'
Depreciation and amortization	463,552	550,643
Gain on sale of assets	-27,509	-34,392
(Gain) loss on available-for-sale and trading securities	-2,894,508	317,206
Gain on sale of investment in real estate	-480,108	0
Deferred income taxes	0	2,358,623
Stock based compensation	109,462	275,408
Charge for non-controlling interest sale and issuance of stock awards	0	166,666
Foreign currency exchange (gains) losses	-117,176	293,640
Changes in operating assets and liabilities:	'	'
Accounts receivable	-264,065	394,315
Inventories	115,396	141,480
Prepaid expenses	242,776	-151,245
Interest receivable	64,265	25,137
Income tax receivable	67,329	0
Other assets	68,777	-880
Accounts payable	-1,259,108	-75,284
Accrued liabilities	118,575	-6,634,363
Cash from continuing activities	-7,251,677	-12,947,715
Cash from discontinued activities	306,907	-748,076
Net cash from operating activities	-6,944,770	-13,695,791
Cash flows from investing activities	'	'
Sale proceeds of available-for-sale securities	2,650,000	0
Sale proceeds of investment in real estate	2,365,017	0
Sale proceeds of trading securities	903,949	94,669
Purchase of trading securities	0	-211,248
Sales proceeds of equipment	14,270	51,325
Purchase of equipment	-35,108	-159,919
Cash from continuing activities	5,898,128	-225,173
Cash from discontinued activities	5,245,600	14,000
Net cash from investing activities	11,143,728	-211,173
Cash flows from financing activities	'	'
Principal payments on notes payable	-1,132,923	-128,296
Proceeds from notes payable	0	116,339
Payments on capital lease	-118,805	-94,044
Contributions from, purchases of and distributions to noncontrolling interest holders, net	0	100,000
Cash from continuing activities	-1,251,728	-6,001
Cash from discontinued activities	0	0
Net cash from financing activities	-1,251,728	-6,001
Effect of exchange rate changes on cash	0	236,022
Net change in cash and cash equivalents	2,947,230	-13,676,943
Cash and cash equivalents at beginning of year	10,638,217	24,315,160
Cash and cash equivalents at end of year	13,585,447	10,638,217
Cash paid during year for:	'	'
Interest	212,915	751,082
Income taxes	0	0
Non-cash investing and financing activities:	'	'
Unrealized change in fair value of available-for-sale securities	971,206	1,910,234
Purchase of equipment under capital lease	$115,359	$0

Significant_Accounting_Policie

Significant Accounting Policies	12 Months Ended
	Aug. 31, 2013
Accounting Policies [Abstract]	'
Significant Accounting Policies [Text Block]	'
	1	Significant Accounting Policies
	Business and Organization
	Dynacq Healthcare, Inc., a Nevada corporation (the “Company”), is a holding company that through its subsidiaries in the United States develops and manages general acute care hospitals that principally provide specialized surgeries.  The Company through its United States subsidiaries owns and operates one general acute care hospital in Pasadena, Texas.  The Company through its subsidiary in Hong Kong invests in debt and equity securities, including short-term investments in initial public offerings and pre-initial public offerings.
	The Company was incorporated under the laws of the State of Nevada in 1992. The Company was reincorporated in Delaware in November 2003 and reincorporated back in Nevada in August 2007.
	U.S. Division
	In the United States, the Company manages and operates one general acute care hospital that principally provides specialized surgeries such as bariatric, orthopedic and neuro-spine surgeries.
	In May 1998, Vista Community Medical Center, L.L.C., a Texas limited liability company, was organized for the purpose of operating a hospital (the "Pasadena facility").  In June 2003, the Pasadena facility was converted to a limited liability partnership. As of August 31, 2013 and 2012, the Company through its subsidiaries had a 98% and 99%, respectively, ownership interest in the Pasadena facility.
	In July 2003, Vista Hospital of Dallas, LLP was organized for the purposes of acquiring and operating a surgical hospital in Garland, Texas (the "Garland facility").  The Company closed the Garland facility in September 2011, and sold it in July 2013.  The Garland facility’s operations for the fiscal years ended August 31, 2013 and 2012 are classified as discontinued operations.
	Corporate Division
	The Company organized Sino Bond Inc. Limited, a Hong Kong corporation (“Sino Bond”) to hold and manage investments in Hong Kong.  Sino Bond invests in debt and equity securities in Europe and Asia, including initial public offerings and pre-initial public offerings.
	The Company’s previous operations in China conducted through a wholly owned subsidiary, Dynacq-Huai Bei, ceased in February 2011, were classified as discontinued operations, and were exited completely in August 2012.
	Reclassification
	Certain previously reported financial information has been reclassified to conform to the current year’s presentation.  The impact of such reclassification was not significant to the prior year’s overall presentation.
	Principles of Consolidation
	The consolidated financial statements include the accounts of the Company and its wholly and majority owned subsidiaries. Intercompany accounts and transactions have been eliminated in consolidation.
	Basis of Presentation
	The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for annual financial information and with the instructions to Form 10-K and Article 3 and 3-A of Regulation S-X. The majority of the Company's expenses are "cost of revenue" items. Costs that could be classified as general and administrative by the Company would include the corporate office costs, which were approximately $5.0 million and $4.7 million for the fiscal years 2013 and 2012, respectively.
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The most significant of the Company's estimates is the determination of revenue to recognize for the services the Company provides and the determination of allowances, which includes the contractual allowances and the provision for doubtful accounts. See “Revenue Recognition” below for further discussion. Actual results could differ materially from those estimates used in preparation of these financial statements.
	Cash and Cash Equivalents
	The Company considers all highly liquid instruments with maturities of three months or less on the date of purchase to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value.
	Investments in Available-for-Sale and Trading Securities
	The Company’s investments in debt instruments (corporate and municipal bonds) are recorded at fair value based on quoted market prices that are traded in less active markets or priced using a quoted market price for similar investments or are priced using non-binding market consensus prices that can be corroborated by observable market data (Level 2).  These investments are classified as available-for-sale securities.  These investments are subject to default risk.  Unrealized gains in the fair value are reported in accumulated other comprehensive income, net of related income tax effect.  The Company regularly monitors its investment portfolio for any decline in fair value that is other than temporary and records any such impairment as an impairment loss.  The determination of the gain or loss on the sale of any security is made using the specific identification method.  During the fiscal year ended August 31, 2013, one of these available-for-sale securities with a book cost of $450,500 was called for a gain of $2,199,500.  As of August 31, 2013, the balance of these securities is valued at approximately $17.5 million.
	The Company also invests in initial public offerings of equity securities on the Hong Kong Stock Exchange.  These investments are classified as trading securities, and are carried at fair value as of August 31, 2013 and 2012.  These investments are subject to fluctuations in the market price.  During the fiscal years ended August 31, 2013 and 2012, the Company had a net gain (loss) of $695,008 and $(318,206), respectively, in these securities.
	Investment in Real Estate and Note Payable
	In October 2012, the Company sold an apartment in Hong Kong, which was purchased in March 2010.  The net proceeds from the sale of the apartment were $1,273,402, after repayment of the associated note payable, resulting in a gain on the sale of $480,108.
	In November 2011 and September 2010, the Company borrowed $116,339 and $65,000 as notes payable from a financial institution at an interest rate of 4.5% and 6%, which notes are to be repaid in 36 and 24 monthly installments, respectively, and are secured by specific equipment purchased at our Pasadena facility.  The $65,000 note payable was fully repaid during the quarter ended November 30, 2012.  The Company paid down $41,308 during the fiscal year ended August 31, 2013, and the current and long-term portions of the notes payable as of August 31, 2013 are $40,256 and $6,744, respectively.
	Inventories
	Inventories, consisting primarily of medical supplies, are stated at the lower of cost or market, with cost determined by use of the average cost method.
	Property and Equipment
	Property and equipment are stated at cost. Maintenance and repairs are charged to expense as incurred. Expenditures which extend the physical or economic life of the assets are capitalized and depreciated.
	Depreciation is computed using the straight-line method over the estimated useful lives of the assets ranging from five to 39 years. The Company has classified its assets into three categories. The categories are listed below, along with the useful life for each category.
			Useful Life
	Land			N/A
	Buildings and improvements			39 years
	Equipment, furniture and fixtures			5 years
	The Company also leases equipment under capital leases. Such assets are amortized on a straight-line basis over the lesser of the term of the lease or the remaining useful life of the assets.
	Impairment of Long-lived Assets
	The Company evaluates the carrying value of property, plant and equipment and definite-lived assets whenever a change in circumstances indicates that the carrying value may not be recoverable from the undiscounted future cash flows from operations. If an impairment exists, the net book values are reduced to fair values as warranted.
	Fair Value of Financial Instruments
	The fair value of financial instruments is estimated based on market trading information, where available.  Absent published market values for an instrument or other assets, management uses observable market data to arrive at its estimates of fair value.  Management believes that the carrying amount of cash and cash equivalents, accounts receivable and accrued liabilities approximate fair value. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.  As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability.  A three-level fair value hierarchy prioritizes the inputs used to measure fair value.  The three levels of inputs used to measure fair value are as follows:
	Level 1	Quoted prices in active markets for identical assets or liabilities.
	Level 2	Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and  liabilities in active markets; quoted price for identical or similar assets and liabilities in markets that are not active; or other input that are observable or can be corroborated by observable market data.
	Level 3	Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.
	The following table summarizes our financial assets and liabilities measured and reported in the Company’s statement of financial position at fair value on a recurring basis as of August 31, 2013, segregated among the appropriate levels within the fair value hierarchy:
			Quoted prices in active			Significant other			Significant
			markets for identical			observable inputs			unobservable
			(Level 1)			(Level 2)			(Level 3)
	Assets
	Investments available-for-sale		$	—		$	17,458,985		$	—
	Trading securities			1,071,346			—			—
	The Company’s investments in Level 1 are in equity stocks at a cost of $1,207,335.  The Company’s investments in Level 2 are in perpetual debt instruments (corporate and municipal bonds) traded on the European markets, at a cost of $7,984,646, are recorded at fair value based on quoted market prices that are traded in less active markets or priced using a quoted market price for similar investments or are priced using non-binding market consensus prices that can be corroborated by observable market data (Level 2), and there has been no change in valuation techniques for these investments (Level 2).
	Revenue Recognition
	Background
	The Company's revenue recognition policy is significant because net patient service revenue is a primary component of its results of operations. Revenue is recognized as services are delivered. The determination of the amount of revenue to be recognized in connection with the Company's services is subject to significant judgments and estimates, which are discussed below.
	Revenue Recognition Policy
	The Company has established billing rates for its medical services which it bills as gross revenue as services are delivered.  Gross billed revenues are then reduced by the Company’s estimate of  allowances, which includes the contractual allowance and the provision for doubtful accounts, to arrive at net patient service revenues.  Net patient service revenues may not represent amounts ultimately collected.  The Company adjusts current period revenue for differences in estimated revenue recorded in prior periods and actual cash collections.
	The following table shows gross revenues and allowances for fiscal years 2013 and 2012:
			2013				2012
	Gross billed charges		$	19,498,962			$	19,619,903
	Allowances			13,441,551				14,088,670
	Net revenue		$	6,057,411			$	5,531,233
	Allowance percentage			69	%			72	%
The table below sets forth the percentage of our gross patient service revenue by financial class for the fiscal years 2013 and 2012:
		2013				2012
Workers' Compensation			11	%			11	%
Commercial			43	%			40	%
Medicare			28	%			28	%
Medicaid			1	%			1	%
Self-Pay			14	%			16	%
Other			3	%			4	%
Contractual Allowance
The Company computes its contractual allowance based on the estimated collections on its gross billed charges.  The Company computes its estimate by taking into account collections received, up to 30 days after the end of the period, for the services performed and also estimating amounts collectible for the services performed within the last six months.
A significant amount of our net revenue results from Texas workers' compensation claims, which are governed by the rules and regulations of the Texas Department of Workers’ Compensation (“TDWC”) and the workers’ compensation healthcare networks. If our hospital chooses to participate in a network, the amount of revenue that will be generated from workers’ compensation claims will be governed by the network contract.
For claims arising prior to the implementation of workers’ compensation networks and out of network claims, inpatient and outpatient surgical services are either reimbursed pursuant to the Acute Care In-Patient Hospital Fee Guideline or at a "fair and reasonable" rate for services in which the fee guideline is not applicable.  Starting March 1, 2008, the Texas Workers’ Compensation 2008 Acute Care Hospital Outpatient and Inpatient Facility Fee Guidelines (the “Guidelines”) became effective. Under these Guidelines, the reimbursement amounts are determined by applying the most recently adopted and effective Medicare reimbursement formula and factors; however, if the maximum allowable reimbursement for the procedure performed cannot be calculated using these Guidelines, then reimbursement is determined on a fair and reasonable basis.
Based on these Guidelines, the reimbursement due the Company for workers’ compensation cases is lower than we previously experienced.  The Company has continued accepting Texas workers’ compensation cases, and has not made any substantial changes in its focus towards such cases.  Our net patient service revenue for Texas workers’ compensation cases as a percentage of gross billings has decreased primarily as a result of lower reimbursement rates for workers’ compensation procedures still being performed.
Should we disagree with the amount of reimbursement provided by a third-party payer, we are required to pursue the medical dispute resolution (“MDR”) process at the TDWC to request proper reimbursement for services.  From January 2007 to November 2008, the Company had been successful in its pursuit of collections regarding the stop-loss cases pending before the State Office of Administrative Hearings (“SOAH”), receiving positive rulings in over 90% of its claims presented for administrative determination.  A 2007 district court decision upholding our interpretation of the statute as applied to the stop-loss claims was appealed by certain insurance carriers, and on November 13, 2008 the Third Court of Appeals determined that in order for a hospital to be reimbursed at 75% of its usual and customary audited charges for an inpatient admission, the hospital must not only bill at least $40,000, but also show that the admission involved unusually costly and unusually extensive services. Procedurally, the decision means that each case where a carrier raised an issue regarding whether the services provided were unusually costly or unusually extensive would be remanded to either SOAH or MDR for a case-by-case determination of whether the services provided meet these standards.  As a result of the Third Court of Appeals opinion, any stop-loss cases pending at SOAH have been remanded to the TDWC since these cases have not been reviewed or decided by the two-prong standard decided by the Third Court of Appeals.  The SOAH Administrative Law judges determined that the most appropriate location for these cases is the TDWC.
A petition asking the Texas Supreme Court to review the Third Court of Appeals decision has been denied. Therefore, the Company is bound by the Third Court of Appeals decision.  The Texas Supreme Court’s decision delayed final adjudication in these pending stop-loss cases.  The uncertain outcome in these cases will depend on a very lengthy process.  We anticipate further, lengthy litigation at the Travis County District Courts and the Texas Courts of Appeals. Because of this lengthy process and the uncertainty of recovery in these cases, collection of a material amount of funds in these pending stop-loss cases cannot be anticipated.
Through August 2013, insurance carriers have voluntarily paid the awards in the decisions and orders issued by SOAH, plus interest, in approximately 180 cases, involving approximately $11 million in claims.  In most of these cases, when the payments were made, the carriers requested refunds of the payments made in the event that the SOAH decisions and orders were reversed on appeal (which they were).  Our request that the TDWC Commissioner enforce the awards which were not voluntarily paid by the carriers was refused in approximately 130 cases.  As a result of the reversal of the SOAH decisions and orders, Texas Mutual Insurance Company and other carriers filed petitions in Travis County district court seeking a refund in cases in which the awards were voluntarily paid.  The district court found in favor of Texas Mutual and the Company was ordered to refund approximately $4.2 million, including prejudgment interest, pending remand for a case-by-case determination of whether the services provided were unusually costly and unusually extensive.  The Company did not object to the reversal and remand of the SOAH decisions and orders, but did object to the judgments ordering refunds and those judgments were appealed to the Third Court of Appeals.  As part of the appeals, the Company deposited the amounts that were ordered to be refunded as cash deposits into the registry of the court in order to stay execution of the judgments ordering refunds.  On June 6, 2013, the judgments ordering refunds were reversed by the Court of Appeals.  The Court of Appeals held that if Texas Mutual wants a refund, it must pursue the refund demand administratively through the TDWC rather than through the district courts.  Texas Mutual filed a motion for rehearing with the Court of Appeals which ultimately was denied.  The Vista entities have filed motions in all 47 cases with the district court asking that the district clerk be ordered to release the deposited funds to the Vista entities.  These motions are pending.  In addition, Texas Mutual filed three additional petitions in district court for cases that were left out of the original 47.  The court granted Texas Mutual’s petitions and ordered the Vista entities to refund approximately $300,000, including prejudgment interest to Texas Mutual.  These judgments were granted before the Court of Appeals reversed the district court’s original judgments.  These three cases have been appealed to the Court of Appeals and the funds ordered refunded have been deposited with the district clerk.  The Company expects that in due course these three additional judgments will be reversed.  If the Court of Appeals’ decision holds, all of the money deposited into the registry of the court will be refunded to the Company.  At this time, Texas Mutual has not decided whether to file a petition for review with the Supreme Court of Texas.  Should Texas Mutual be successful in reversing the Court of Appeals’ decision, we anticipate that similar motions requesting remand and a refund for awards voluntarily paid will be filed and will likely be granted by the 345th Judicial District Court of Travis County, Texas.   If and when these additional motions are granted, the Company will be ordered to refund an additional $8.1 million, not including prejudgment interest.  As of August 31, 2013, the Company has accrued this amount of $8.1 million, and an additional amount of $2.2 million in interest payable, as accrued liabilities.  If the Court of Appeals’ decision holds, we do not anticipate that any other carriers will pursue refund demands through district court but instead will pursue them administratively through TDWC.   The cases in which the SOAH decisions and orders were reversed have been or are being remanded to TDWC for determinations of whether the services provided were unusually costly and unusually extensive. Voluntary payments made pursuant to the Decisions and Orders are premature payments by the carriers and may be ordered to be refunded.  Once the Company is given the opportunity to present its evidence regarding whether the services provided were unusually costly and unusually extensive, the Company anticipates that it will prevail in many of the underlying stop-loss fee disputes and that payments refunded to the carriers will be recaptured.
Due to the uncertainties associated with these stop-loss fee dispute cases, the Company recognized increases in the contractual allowance at our Pasadena facility of $10,254,990 and $149,875 during fiscal years 2011 and 2013, respectively, (and an additional amount of $779,583 and $136,542 in the contractual allowance during fiscal years 2011 and 2013, respectively, at our Garland facility, which is classified as discontinued operations), and interest expense of $1,751,478, $547,366 and $548,113 for the fiscal years 2011, 2012 and 2013, respectively, at our Pasadena facility (and an additional interest expense of $132,339, $42,954 and $44,829 for the fiscal years 2011, 2012 and 2013, respectively, at our Garland facility).
Claims regarding payment for ambulatory surgical center and hospital outpatient services remain pending at the TDWC.  It is expected that these claims will be adjudicated at SOAH and possibly in the Texas district and appellate courts. The basis for reimbursement for these services made the subject of these pending cases is the determination of “fair and reasonable” charges.  In 2007, we received unfavorable rulings from SOAH in all of our appeals of unfavorable decisions related to services provided in 2001 and 2002.  The 179 cases, which were appealed to the Travis County district courts, challenged the constitutionality of the relevant statutory language.  The Company received an unfavorable ruling in its lead case in March 2009, which ruling was appealed to and was upheld by the Third Court of Appeals on August 26, 2010.  The Texas Supreme Court denied a petition asking for review of the Third Court of Appeals decision.  The unfavorable interpretation by the Texas Courts of Appeal in our lead case negatively affects the recovery of additional reimbursement, not only in the lead case, but in the remaining 178 pending cases.  Consequently, the Company is bound by the Third Court of Appeals’ ruling that interprets the applicable statute and fee guideline to require that the amount that will be paid to a provider must not only be at a “fair and reasonable rate” but also must “ensure the quality of medical care” and “achieve effective cost control” and be the same or less than that charged to others with an equivalent standard of living.  This ruling will impact cases in which a fee guideline was not applicable, specifically all pending cases involving ambulatory surgical services provided from 2001 through 2004 as well as all pending cases involving hospital outpatient services provided prior to March 1, 2008, when the Guidelines took effect.  Since the Third Court of Appeals’ unfavorable ruling, collection, if any, in these cases depends on the Company’s ability to establish the criteria in this ruling. The Company was given the opportunity to establish the criteria in approximately 80 cases, which were set for hearing on the merits from March through May 2012 and was unsuccessful.  Additionally, there are several thousand ambulatory surgical center and hospital outpatient cases pending at SOAH which will be heard beginning in January, 2014.  Settlement offers have been made in the vast majority of these cases and the Company has been successful in settling many of the cases in which offers were made.  Even so, it is likely that hundreds, if not more than a thousand, of these cases may go to hearing at SOAH at which the Company will have the opportunity to continue to establish the criteria in the cases still pending at SOAH during the 2014 fiscal year.
Due to the uncertainties regarding the accounts receivable in the MDR process, the 2008 and 2010 Third Court of Appeals’ opinions and our legal counsel’s advice that settlements with insurance carriers in stop-loss cases have virtually stopped, the Company had fully reserved all accounts receivable related to the MDR process as of August 31, 2008.  The Company is in active settlement negotiations with insurance carriers for ambulatory surgical center and hospital outpatient cases.  Any monies collected for these MDR accounts receivable will be recorded as current period’s net patient service revenues.
Provision for Doubtful Accounts
Although outcomes vary, our policy is to attempt to collect amounts due from patients, including co-payments and deductibles due from patients with insurance, at the time of service while complying with all federal and state laws and regulations. In non-emergency circumstances or for elective procedures and services, it is our policy to verify insurance prior to a patient being treated; however, there are various exceptions that can occur.
The Company computes its allowances based on the estimated collections on its gross billed charges.  The Company computes its estimate of allowance, which is a combination of contractual allowance and provision for doubtful accounts, by taking into account collections received, up to 30 days after the end of the period, for the services performed and also estimating amounts collectible for the services performed within the last six months.
Accounts receivable represent net receivables for services provided by the Company.  At each balance sheet date management reviews the accounts receivable for collectibility and provides full allowance reserves for any accounts receivable deemed uncollectible.
The allowances stated as a percentage of gross receivables at the balance sheet dates is larger than the allowance percentage used to reduce gross billed charges due to the application of partial cash collections to the outstanding gross receivable balances, without any adjustment being made to the allowances. The allowance amounts netted against gross receivables are not adjusted until such time as the final collections on an individual receivable are recognized.
The focal point of our business is providing patient care services, including complex orthopedic and bariatric procedures. The Company pursues optimal reimbursement from third-party payers for these services. In some instances, we do not have contractual arrangements with third-party payers which provide for “prompt payment” which may result in additional time to collect the expected reimbursement.
The collection process may also be extended due to our efforts to obtain all optimal reimbursement available to the Company. Specifically, for medical services provided to injured workers, the Company may initially receive reimbursement that may not be within the fee guidelines or regulatory guidelines mandating reimbursement. The Company reviews and pursues those particular claims that are determined to warrant additional reimbursement pursuant to the fee or regulatory guidelines. The Company's pursuit of additional reimbursement amounts that it believes are due under fee or regulatory guidelines may be accomplished through established dispute resolution procedures with applicable regulatory authorities.
Stock Based Compensation
The Company estimates the fair value of stock options granted using the Black-Scholes option pricing model. The fair value for awards that are expected to vest is then amortized on a straight-line basis over the requisite service period of the award, which is generally the option vesting term. The amount of expense attributed is based on estimated forfeiture rate, which is updated based on actual forfeitures as appropriate. This option pricing model requires the input of highly subjective assumptions, including the expected volatility of our common stock, pre-vesting forfeiture rate and an option’s expected life. The financial statements include amounts that are based on the Company’s best estimates and judgments.
Advertising Costs
Advertising and marketing costs in the amounts of $125,000 and $162,000 for the fiscal years ended August 31, 2013 and 2012, respectively, were expensed as incurred.  In fiscal year 2012, the Company reversed $870,000 of marketing costs that were expensed and accrued for in fiscal year 2011, since the amounts were determined to be not payable.
Income Taxes
The Company uses the liability method in accounting for income taxes. Under this method, deferred tax liabilities or assets are determined based on differences between the income tax basis and the financial reporting basis of assets and liabilities and are measured using the enacted tax rates and laws that are expected to be in effect when the differences are expected to reverse.  If the Company is uncertain about its ability to recognize benefit from net operating losses, it records a valuation allowance against deferred tax assets.
Noncontrolling Interest
The equity of minority investors (minority investors are generally physician groups and other healthcare providers that perform surgeries at the Company's facilities) in certain subsidiaries of the Company is reported on the consolidated balance sheets as noncontrolling interest. Noncontrolling interest reported in the consolidated income statements reflect the respective interests in the income or loss of the limited partnerships or limited liability companies attributable to the minority investors (equity interests ranged from 1.75% to 2.00% during the fiscal year ended August 31, 2013).
The following table sets forth the activity in the noncontrolling interest account for the fiscal years ended August 31, 2013 and 2012:
Balance August 31, 2011		$	63,617
Loss allocated to noncontrolling interest holders			-47,358
Capital contributions from/distributions to new noncontrolling interest holders, net			50,000
Balance August 31, 2012			66,259
Loss allocated to noncontrolling interest holders			-2,836
Balance August 31, 2013		$	63,423
Earnings (Loss) per Share
Earnings (loss) per share has been computed using the weighted average number of common shares outstanding during the period. Diluted net income (loss) per share has been calculated to give effect to the dilutive effect of common stock equivalents consisting of stock options in years in which the Company has income. The calculation of dilutive shares outstanding excludes 1,096,475 options and 2,790,566 options outstanding as of August 31, 2013 and 2012, respectively, because their effect is antidilutive.
Foreign Currency Translation
The functional currency of the Company as a whole is the U.S. Dollar.  The Company has designated the U.S. Dollar as the functional currency for Sino Bond in Hong Kong. The effects of foreign currency exchange adjustments are included as a component of Rent and Other Income in the Consolidated Statements of Operations.
Recent Accounting Pronouncements
No recent accounting pronouncements or other authoritative guidance has been issued that management considers likely to have a material impact on our consolidated financial statements.

Property_and_Equipment

Property and Equipment	12 Months Ended
	Aug. 31, 2013
Property, Plant and Equipment [Abstract]	'
Property, Plant and Equipment Disclosure [Text Block]	'
	2.     Property and Equipment
	At August 31, property and equipment consisted of the following:
		2013		2012
	Land	$	497,110	$	497,110
	Buildings and improvements		8,989,115		8,989,115
	Equipment, furniture and fixtures (including equipment under capital lease of		8,528,872		10,058,232
	$585,450 and $470,091)
			18,015,097		19,544,457
	Less accumulated depreciation and amortization (including amortization		-11,691,440		-12,888,637
	for equipment under capital lease of $449,860 and $340,461)
	Net property and equipment	$	6,323,657	$	6,655,820
	For the fiscal years ended August 31, 2013 and 2012, depreciation and amortization expense was $463,552 and $550,643, respectively.

Discontinued_Operations

Discontinued Operations	12 Months Ended
	Aug. 31, 2013
Discontinued Operations And Disposal Groups [Abstract]	'
Disposal Groups Including Discontinued Operations Disclosure [Text Block]	'
	3.     Discontinued Operations
	The Company classifies assets to be disposed of as held for sale or, if appropriate, discontinued operations when appropriate approvals for the disposal are made by management or the Board of Directors (the “Board”). Cash flows from discontinued businesses are reflected as discontinued operating, investing, and financing activities in our statement of cash flows.
	The Company closed the Garland facility on September 30, 2011, and sold it in July 2013. The Company took an impairment charge of approximately $1.1 million during the quarter ended August 31, 2012, based on the sales price negotiated at that time.  An additional loss of $122,975 was taken based on the final sales price during the quarter ended August 31, 2013.  The Company continues collection efforts on accounts receivable for procedures conducted at the Garland Facility.  While these accounts receivable are fully offset by an allowance for doubtful accounts, any cash collections are reported as revenues when received.
	The Company’s previous operations in China conducted through a wholly owned subsidiary, Dynacq-Huai Bei, ceased in February 2011, were classified as discontinued operations, and were exited completely in August 2012.
	The following is a summary of financial information related to our discontinued operations for the fiscal years ended August 31, 2013 and 2012:
	Discontinued Operations
		Year Ended August 31, 2013						Year Ended August 31, 2012
		Garland		China		Total		Garland		China		Total
		Facility		Operations				Facility		Operations
	Net patient service revenue	$	451,965	$	—	$	451,965	$	397,278	$	—	$	397,278
	Costs and expenses:
	Compensation and benefits		32,415		—		32,415		181,693		22,644		204,337
	Medical services and supplies		-8,301		—		-8,301		235,977		—		235,977
	Other operating expenses		158,061		—		158,061		957,090		-363,148		593,942
	Asset impairment charge		—		—		—		1,058,056		—		1,058,056
	Depreciation and amortization		—		—		—		—		82,353		82,353
	Total costs and expenses		182,175		—		182,175		2,432,816		-258,151		2,174,665
	Operating income (loss)		269,790		—		269,790		-2,035,538		258,151		-1,777,387
	Other income (expense), net		4,600		—		4,600		304,673		77,730		382,403
	Income (loss) before income taxes		274,390		—		274,390		-1,730,865		335,881		-1,394,984
	Benefit for income taxes		—		—		—		—		—		—
	Income (loss) on discontinued operations, net of taxes		274,390		—		274,390		-1,730,865		335,881		-1,394,984
	Loss on disposal of discontinued assets		-122,975		—		-122,975		—		-229,201		-229,201
	Benefit for income taxes		—		—		—		—		—		—
	Loss on disposal of discontinued operations, net of taxes		-122,975		—		-122,975		—		-229,201		-229,201
	Total income (loss) on discontinued operations,	$	151,415	$	—	$	151,415	$	-1,730,865	$	106,680	$	-1,624,185
	net of taxes
		August 31, 2013						August 31, 2012
		Garland		China		Total		Garland		China		Total
		Facility		Operations				Facility		Operations
	Current assets	$	—	$	—	$	—	$	—	$	—	$	—
	Property and equipment, net		—		—		—		5,401,092		—		5,401,092
	Total assets	$	—	$	—	$	—	$	5,401,092	$	—	$	5,401,092
	Current liabilities:
	Accounts payable and accrued liabilities	$	—	$	—	$	—	$	—	$	—	$	—
	Total liabilities	$	—	$	—	$	—	$	—	$	—	$	—

Notes_payable

Notes payable	12 Months Ended
	Aug. 31, 2013
Debt Disclosure [Abstract]	'
Debt Disclosure [Text Block]	'
	4.     Notes payable
	At August 31, notes payable consisted of the following:
		2013		2012
	Note payable secured by the apartment in Hong Kong.	$	—	$	1,091,615
	The Company obtained an 18-year mortgage loan of $1,245,775
	from a financial institution, with a variable interest rate at the lower of 3-month
	Hang Seng Interbank Offered Rates plus 0.7% or 2.9% below the Hong Kong
	Dollar best lending rate quoted by the financial institution. In fiscal year 2013,
	the apartment was sold, and the related note payable was also paid off.
	Notes payable for $116,339 and $65,000 for purchases of equipment for the		47,000		88,307
	Pasadena facility at an interest rate of 4.5% and 6%, secured by the said
	equipment.
	Total		47,000		1,179,922
	Less: Current portion		-40,256		-105,735
	Long-term portion	$	6,744	$	1,074,187
	Principal payments due on the note payable in fiscal years 2014 and 2015 are $40,256 and $6,744, respectively.

Income_Taxes

Income Taxes	12 Months Ended
	Aug. 31, 2013
Income Tax Disclosure [Abstract]	'
Income Tax Disclosure [Text Block]	'
	5.     Income Taxes
	The provision (benefit) for income taxes consisted of the following:
		Year Ended August 31,
		2013		2012
	Current tax (benefit) expense:
	Federal	$	–	$	–
	State		–		–
	Total current		–		–
	Deferred tax (benefit) expense:
	Federal		–		4,018,699
	State		–		–
	Total deferred		–		4,018,699
	Total income tax expense	$	–	$	4,018,699
	As of August 31, 2012 there was an income tax expense of $4,018,699.  The Company had anticipated collecting significant amounts of money from the MDR cases, which were fully reserved, to offset some of the prior years’ losses but has not been successful as yet.  In addition, the Company in fiscal years 2013 and 2012 continued to have operating losses.  The Company believes that the likelihood of realizing future tax benefit for the deferred tax assets is low, and hence increased the valuation allowance to write-off the deferred tax assets.
	The components of the provision (benefit) for deferred income taxes at August 31 were as follows:
		2013		2012
	Applicable to:
	Net operating loss carryforward	$	-1,611,973	$	-4,941,754
	Differences between revenues and expenses recognized for		246,396		2,172,058
	federal income tax and financial reporting purposes
	Difference in method of computing depreciation for tax and		26,981		49,061
	financial reporting purposes
	Changes in valuation allowance		1,338,596		6,739,334
	Deferred income tax expense	$	–	$	4,018,699
	Significant components of the Company's deferred tax liabilities and assets were as follows at August 31, 2013:
		Current		Noncurrent
	Deferred tax liabilities:
	Depreciation	$	–	$	-207,396
	Deferred tax assets:
	Net operating loss carryforward		–		9,439,548
	Revenue and expense differences		13,157		3,580,862
	Allowance for uncollectible accounts		513,456		–
	Other		-166,758		-29,869
	Valuation allowance		-359,855		-12,783,145
	Net deferred tax asset (liability)	$	–	$	–
	Significant components of the Company's deferred tax liabilities and assets were as follows at August 31, 2012:
		Current		Noncurrent
	Deferred tax liabilities:
	Depreciation	$	–	$	-180,415
	Deferred tax assets:
	Net operating loss carryforward		–		7,827,575
	Revenue and expense differences		54,664		3,342,010
	Allowance for uncollectible accounts		513,456		–
	Asset impairment		370,320		–
	Other		-166,758		43,551
	Valuation allowance		-771,682		-11,032,721
	Net deferred tax asset (liability)	$	–	$	–
	In assessing the ability to realize deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies in making this assessment.  Due to the uncertainty of the Company’s ability to recognize the benefit from the net operating losses, the Company has recorded a full valuation allowance against the deferred tax assets as at August 31, 2013 and 2012.
	The Company recognizes tax benefits only for tax positions that are more likely than not to be sustained upon examination by tax authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50% likely to be realized upon settlement. Unrecognized tax benefits are tax benefits claimed in the Company’s tax returns that do not meet these recognition and measurement standards.
	A reconciliation of the benefit for income taxes with amounts determined by applying the statutory federal income tax rate to income before income taxes and noncontrolling interests is as follows:
		Year Ended August 31,
		2013		2012
	Benefit for income taxes computed using the statutory rate of 35%	$	-1,210,767	$	-2,294,590
	Noncontrolling interest in loss of consolidated subsidiaries		993		16,575
	Non-deductible expenses		-128,822		-442,620
	Changes in valuation allowance		1,338,596		6,739,334
	Expense for income taxes	$	—	$	4,018,699
	The Company files income tax returns in the U.S. federal and foreign jurisdictions.  The federal statute limitation is open for tax year ending on and after August 31, 2010 and the State of Texas statute limitation is open for the report years 2010 through 2013.  The Company is currently undergoing an IRS examination of its tax year ending August 31, 2011.  The IRS has not proposed any adjustment or reached a conclusion from this examination.At August 31, 2013, we had approximately $27.0 million of federal net operating loss carryforwards, which, if not utilized, will expire at various dates from 2031 through 2033.

Related_Party_Transactions

Related Party Transactions	12 Months Ended
	Aug. 31, 2013
Related Party Transactions [Abstract]	'
Related Party Transactions Disclosure [Text Block]	'
		6	Related Party Transactions
	The Company has retained Redwood Health Corporation (“Redwood”), to furnish physicians to provide in-house emergency medical coverage for its Pasadena facility during the weekend hours and weekday nights at an hourly rate of $75.  The Company’s chief executive officer is a physician and an affiliate of Redwood.  The Company paid $397,050 and $421,725 for emergency room physician services to Redwood in fiscal years 2013 and 2012, respectively. Management, as well as the Audit Committee that approved the agreement, believes that the hourly rate being paid is consistent with comparable in-house emergency medical coverage rates available in the area.
	Dr. Ping Chu, a director of the Company until October 30, 2012, paid the Company $3,831 and $14,938 during fiscal years ended August 31, 2013 and 2012, respectively for rent and management fees.   As of August 31, 2013 and 2012, the Company had accounts receivable from Dr. Chu of $-0- and $46,848, respectively. Included in the accounts receivable balance were amounts applicable to Dr. Chu's staffs' payroll for which he reimbursed the Company in the ordinary course of business.
	During the fiscal year 2009, the Company retained Anesthesia Associates of Houston Metroplex to provide exclusive, continuous and uninterrupted anesthesiology services, including physicians and CRNAs, to the Pasadena facility for a monthly compensation of $5,000.  The Company’s chief executive officer is a physician and an affiliate of Anesthesia Associates of Houston Metroplex.  The Company paid $60,000 for anesthesiology services to said organization in each of the fiscal years 2013 and 2012. Management, as well as the Board that approved the agreement, believes that the rate being paid is consistent with comparable in-house anesthesiology services rates available in the area.  During the fiscal year 2009, the Company also retained Redwood to locate and recruit additional skilled anesthesiologists and CRNAs for its Pasadena facility for a monthly compensation of $20,000.  The Company paid $240,000 for said recruitment services to Redwood in each of the fiscal years 2013 and 2012. Management, as well as the Board that approved the agreement, believes that the rate being paid is consistent with comparable rates for recruitment available in the area.  The Company entered into these two agreements in order to replace the previous anesthesiology group, whose contract terminated at the end of fiscal year 2009.  The compensation which was being paid to the previous group was substantially the same as that being paid under the new contracts.
	The Company had purchased artifacts as inventory for re-sale in China during fiscal years 2010 and 2011.  The purchase amount was paid by Mr. Chiu Chan, the Company’s former chief executive officer.  The amount payable to his estate of $231,333 and $270,468, as of August 31, 2013 and 2012, respectively, is included in Accrued Liabilities in the Consolidated Balance Sheet.  The Audit Committee had since approved the purchases by Mr. Chan on behalf of the Company, and believed that these purchases have been made at the prevailing market rates.

Stockholders_Equity_and_Stock_

Stockholders' Equity and Stock Option Plan	12 Months Ended
	Aug. 31, 2013
Stockholders Equity And Stock Option Plan [Abstract]	'
Stockholders Equity And Stock Option Plan [Text Block]	'
		7	Stockholders' Equity and Stock Option Plan
	Preferred Stock
	In January 1992, the Board approved an amendment to the Company's Articles of Incorporation to authorize 5,000,000 shares of undesignated preferred stock, for which the Board is authorized to fix the designation, powers, preferences and rights. There are no shares of preferred stock issued or outstanding.
	Treasury Stock
	The Company did not purchase any treasury shares in fiscal years 2013 and 2012.
	Stock Option Plans
	Year 2011 Stock Incentive Plan
	The purpose of the Year 2011 Stock Incentive Plan (“2011 Plan”) is to strengthen the Company by providing an incentive to its employees, officers, consultants and directors and encouraging them to devote their abilities and industry to the success of the Company’s business enterprise. It is intended that this purpose be achieved by extending to employees, officers, consultants and directors of the Company and its subsidiaries an added long-term incentive for high levels of performance and unusual efforts through the grant of incentive stock options, non-qualified stock options, stock appreciation rights, dividend equivalent rights, performance awards and restricted stock.  The Company has reserved 15,000,000 shares of common stock for issuance under the 2011 Plan.
	On November 14, 2011, the Compensation Committee granted stock options to purchase an aggregate of 200,000 shares under the 2011 Plan, with a weighted average exercise price of $1.07 to two employees.  These stock options were canceled before vesting.
	On January 12, 2012, the Compensation Committee granted stock options to purchase 250,000 shares under the 2011 Plan, with an exercise price of $1.10 to the Company’s chief executive officer, Eric K. Chan.  These stock options vest in annual installments of 25 percent beginning on the first anniversary date, and expire after ten years.  The shares underlying these stock options are registered under the Securities Act.
	On February 6, 2012, the Compensation Committee granted stock options to purchase an aggregate of one million shares under the 2011 Plan, with a weighted average exercise price of $1.00 to various employees.  All these grants were canceled before they vested.
	As of August 31, 2013, there remain 250,000 shares to be issued upon exercise of outstanding options, and 14,750,000 shares which can be issued under the 2011 Plan after giving effect to shares issued and canceled.
	2000 Incentive Plan
	The Company's 2000 Incentive Plan ("2000 Plan") provides for options and other stock-based awards that may be granted to eligible employees, officers, consultants and non-employee directors of the Company or its subsidiaries.  The Company had reserved 5,000,000 shares of common stock for future issuance under the 2000 Plan.  The 2000 Plan does not have a fixed termination date, provided that no incentive stock option can be granted subsequent to August 29, 2011.  As of August 31, 2013, there remain 846,475 shares to be issued upon exercise of outstanding options, and no new stock options awards will be issued under the 2000 Plan.
	The following table summarizes the stock option activities for the fiscal year ended August 31, 2013 (share amounts in thousands):
						Weighted Average
						Option Exercise
			Shares			Price Per Share
	Outstanding, August 31, 2011			2,206		$	2.41
	Granted			1,450			1.03
	Exercised			—			—
	Expired or canceled			-865			1.68
	Outstanding, August 31, 2012			2,791			1.92
	Granted			—			—
	Exercised			—			—
	Expired or canceled			-1,694			1.74
	Outstanding, August 31, 2013			1,097			2.21
	For the fiscal years ended August 31, 2013 and 2012, there were no stock options exercised. The aggregate intrinsic value of the stock options outstanding as of August 31, 2013 and 2012 is $-0-, since the market price is lower than the exercise price.
	The following summarizes information related to stock options outstanding as of August 31, 2013, and related weighted average price and life information:
				Options Outstanding					Options Exercisable
	Exercise Prices			Number of			Weighted Average		Number of Shares
				Shares			Remaining Contractual
							Life (Years)
				(Share Amounts In Thousands)
	$	1.1			250			8.4		63
	$	1.86			660			7.9		330
	$	4.9			187			1.3		187
	Total				1,097			6.8		580
	For the fiscal years ended August 31, 2013 and 2012, stock-based compensation expense associated with the Company’s stock options and stock grants was $109,462 and $325,408, respectively.  The total unrecognized compensation expense for outstanding stock options as of August 31, 2013 was $378,000, and will be recognized, in general, over 1.9 years.
	The fair value of the stock-based awards in fiscal year 2012 was $754,224 and was estimated using the Black-Scholes model with the following weighted average assumptions:
			Year Ended August 31, 2012
	Estimated fair value per share		$	0.52
	Expected life (years)			4.1
	Risk free interest rate			0.79	%
	Volatility			78	%
	Dividend yield			—

Employee_Benefit_Plan

Employee Benefit Plan	12 Months Ended
	Aug. 31, 2013
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]	'
Compensation and Employee Benefit Plans [Text Block]	'
	8.     Employee Benefit Plan
	The Company sponsors a 401(k) defined contribution plan covering substantially all employees of the Company and provides for voluntary contributions by these employees, subject to certain limits. The plan was effective June 1, 2001. The Company makes discretionary contributions to the plan. The Company's contributions for fiscal years 2013 and 2012 were $29,092 and $32,322, respectively.

Net_Income_Loss_Per_Share

Net Income (Loss) Per Share	12 Months Ended
	Aug. 31, 2013
Earnings Per Share [Abstract]	'
Earnings Per Share [Text Block]	'
	9	Net Income (Loss) Per Share
	The following table presents the computation of basic and diluted earnings (loss) per common share attributable to the Company:
			Year Ended August 31,
			2013		2012
	Basic and diluted earnings (loss):
	Numerator:
	Loss from continuing operations		$	-3,459,335	$	-10,574,669
	Less: Net loss attributable to noncontrolling interest			2,836		47,358
	Loss from continuing operations attributable to Dynacq Healthcare, Inc.			-3,456,499		-10,527,311
	Income (loss) from discontinued operations, net of income taxes			151,415		-1,624,185
	Net loss attributable to Dynacq Healthcare, Inc.		$	-3,305,084	$	-12,151,496
	Denominator:
	Basic and diluted average common shares outstanding			14,543,626		14,489,780
	Basic and diluted earnings (loss) per common share:
	Loss from continuing operations attributable to Dynacq Healthcare, Inc.		$	-0.24	$	-0.73
	Income (loss) from discontinued operations, net of income taxes			0.01		-0.12
	Net loss attributable to Dynacq Healthcare, Inc.		$	-0.23	$	-0.85
	Basic net income (loss) per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of common shares outstanding for the reporting period. Diluted net income (loss) per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock.  For the calculation of diluted net income (loss) per share, the basic weighted average number of shares is increased by the dilutive effect of stock options determined using the treasury stock method. However, if it is anti-dilutive, the dilutive effect of the stock options is not included in the calculation of diluted net income (loss) per share.  Stock options with exercise prices exceeding current market prices that were excluded from the computation of net income (loss) per share amounted to  1,096,475 shares and 2,790,566 shares as of August 31, 2013 and 2012, respectively.

Other_Comprehensive_Income_Los

Other Comprehensive Income (Loss) and Accumulated Other Comprehensive Income	12 Months Ended
	Aug. 31, 2013
Equity [Abstract]	'
Comprehensive Income Note [Text Block]	'
		10	Other Comprehensive Income (Loss) and Accumulated Other Comprehensive Income
	The following table presents information about items reclassified out of accumulated other comprehensive income (loss) by component for the fiscal year ended August 31, 2013 (net of tax):
			Change in Foreign		Change in Fair		Accumulated
			Currency		Value of Available-		Other
			Translation		for-Sale Securities		Comprehensive
			Adjustment				Income (Loss)
	Balance as of August 31, 2012		$	8,196	$	8,411,128	$	8,419,324
	Other comprehensive income before			—		3,170,706		3,170,706
	reclassifications
	Amounts reclassified from accumulated			-8,196		-2,199,500		-2,207,696
	other comprehensive income
	Net current-period other comprehensive			-8,196		971,206		963,010
	income (loss)
	Balance as of August 31, 2013		$	—	$	9,382,334	$	9,382,334
	The following table presents a subtotal for each significant reclassification to net income out of accumulated other comprehensive income (loss) and the line item affected in the consolidated statement of operations during the fiscal year ended August 31, 2013:
	Details about accumulated other comprehensive			Amount reclassified	Affected line item in the
	income (loss) components			from accumulated	statement where net
				other comprehensive	income is presented
				income
	Gain on foreign currency translation adjustment		$	12,610	Rent and other income
	Tax provision			-4,414	Accrued liabilities
			$	8,196
	Gain on call of available-for-sale securities		$	2,199,500	Rent and other income
	Tax provision			—
			$	2,199,500
	The components of accumulated other comprehensive income were as follows:
			August 31, 2013		August 31, 2012
	Foreign currency translation adjustment, net of taxes of $-0- and		$	—	$	8,196
	$4,414, respectively
	Change in valuation of investment available-for-sale, net of taxes of $-0- and			9,382,334		8,411,128
	$-0-, respectively
	Total accumulated other comprehensive income, net of taxes of $-0- and		$	9,382,334	$	8,419,324
	$4,414, respectively

Accrued_Liabilities

Accrued Liabilities	12 Months Ended
	Aug. 31, 2013
Payables and Accruals [Abstract]	'
Accounts Payable and Accrued Liabilities Disclosure [Text Block]	'
	11	Accrued Liabilities
	Accrued liabilities at August 31 is as follows:
			2013		2012
	MDR stop-loss cases accrual, including accrued interest		$	10,231,033	$	9,548,602
	Marketing fees liability			300,000		300,000
	Payroll and related taxes			306,450		389,713
	Property taxes			189,202		339,527
	Year-end accruals of expenses and other			818,632		1,185,520
	Total accrued liabilities		$	11,845,317	$	11,763,362

Commitments_and_Contingencies

Commitments and Contingencies	12 Months Ended
	Aug. 31, 2013
Commitments And Contingencies Disclosure [Abstract]	'
Commitments And Contingencies Disclosure [Text Block]	'
		12	Commitments and Contingencies
	Due to the uncertainties associated with the stop-loss fee dispute cases, the Company has accrued an amount of $8.1 million, and an additional amount of $2.2 million in interest payable as accrued liabilities.  For a detailed discussion of this, see Revenue Recognition discussed in Note 1 – Significant Accounting Policies.
	Total rent and lease expenses paid by the Company for the fiscal years 2013 and 2012 were approximately $131,000 and $127,000, respectively.  The Company’s total minimum rental commitments under noncancellable operating leases are approximately $318,000,  of which $70,000, $68,000, $64,000, $58,000 and $58,000 are payable in fiscal years 2014, 2015, 2016, 2017 and 2018.
	The Company has contracts with doctors to manage various areas of the Company's hospital and other service agreements. Payments made under these agreements for the fiscal years ended August 31, 2013 and 2012 were $1,156,000 and $1,190,000, respectively.  The Company’s minimum commitments under these contracts are approximately $793,000, all of which is payable in fiscal year 2014.
	The Company has administrative support services agreements with outside organizations for administrative support services.  Payments made related to these agreements for fiscal years 2013 and 2012 were $440,000 and $266,000, respectively.  The Company has a total commitment of approximately $272,000, of which $263,000, $6,000 and $3,000 are payable in fiscal years 2014, 2015 and 2016, respectively, related to these administrative support services agreements.
	The Company has a note payable commitment for purchase of equipment for the Pasadena facility at an interest rate of 4.5%, secured by the said equipment of approximately $48,000, of which $41,000 is payable in 2014 and $7,000 in 2015.
	These commitments mentioned above total $12.2 million, of which $11.8 million is payable in fiscal year 2014, $113,000 in 2015, $99,000 in 2016, $69,000 in 2017, and $58,000 in 2018.
	Internal Investigation
	As previously disclosed in our Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on August 9, 2012, we announced that, at the request of our Board of Directors (the “Board”), we had commenced an internal investigation of our past business practices, potentially encompassing members of the Board, management and third persons, and related accounting matters (the “Investigation”).
	The Investigation, which was performed by outside legal counsel and other outside consultants at the direction of the Board, was substantially completed on December 27, 2012 at a cost of approximately $2 million. The Investigation included a review of a substantial number of Company documents and emails, as well as interviews with employees, members of the Board and other persons who were familiar with the facts surrounding the Investigation. The results of the Investigation, which were reported directly to the Board, revealed that the former Chief Financial Officer of the Company did not perform a significant review or independent analysis of transactions initiated by the former Chief Executive Officer. As a result, we believe that, for the five fiscal years ending on August 31, 2012, we did not maintain effective control over financial reporting due to the existence of a material weakness related to a failure of internal controls designed to limit the ability of management to override our system of internal controls. The results of the Investigation also revealed that the former Chief Financial Officer misrepresented certain information to our independent auditor, which we have also determined to be a material weakness in our internal control over financial reporting. We also identified the existence of a significant deficiency related to a lack of objectivity by our former executive officers with respect to accounting decisions.
	The former Chief Executive Officer and the former Chief Financial Officer, who occupied these offices during the events in question, are no longer employed by us. Further, we conducted a review of our internal control and compliance policies and procedures, and during November and December of 2012, implemented changes to these policies and procedures designed to improve our internal controls over financial reporting.
	We have determined that our previously reported consolidated balance sheets for periods up to and including August 31, 2012 do not require any material adjustments and/or restatements in respect of the results of the Investigation. Further, the Investigation did not result in any material change to our previously reported net income or loss or financial position for the same periods. However, the Investigation, along with subsequent analysis performed did reveal that Company expenditures in the amount of approximately $7.8 million were authorized by former officers of the Company and paid to various third parties, and the results of the Investigation and the subsequent analysis performed provided no evidence of a discernible benefit to the Company resulting from these expenditures. We have determined that the questionable nature of these expenditures may result in their reclassification in our financial statements, from operating costs and expenses to other expenses, depending on determinations that the Board may make in the future. We do not expect these reclassifications, even if they are made, to result in a material restatement of our financial statements.
	The sole remaining member of our Board is Dr. Eric K. Chan, who also serves as our Chief Executive Officer and President. At the present time, our Board has five vacancies. We intend to seek qualified candidates to fill these Board vacancies, including some candidates that are deemed independent based on the independence standards of NASDAQ. As and when we have independent directors serving on our Board, they will consider whether and if any additional actions are to be pursued by the Company in relation to the Investigation.
	Risks and Uncertainties
	The Company maintains various insurance policies that cover its Pasadena facility including occurrence medical malpractice coverage.  In addition, all physicians granted privileges at the Pasadena facility are required to maintain medical malpractice insurance coverage.  The Company also maintains general liability and property insurance coverage, including flood coverage.  The Company does not currently maintain worker's compensation coverage in Texas.  In regard to the Employee Health Insurance Plan, the Company is self-insured with specific and aggregate re-insurance with stop-loss levels appropriate for the Company's group size.  Coverage is maintained in amounts management deems adequate.
	We do not carry director and officer liability insurance. As permitted under Nevada law and pursuant to our governing documents and indemnification agreements with certain of our officers and directors, we indemnify our directors and officers against monetary damages, including advancing expenses, to the fullest extent permitted by Nevada law.
	On May 21, 2013, Ping S. Chu and James G. Gerace (both former members of our Board of Directors), along with seven other plaintiffs, filed a lawsuit in Probate Court No. 3 of Harris County, Texas, naming as defendants Ella Y.T.C. Chan (in her individual capacity and in her capacity as Independent Executrix of the Estate of Chiu M. Chan, Deceased, our former Chief Executive Officer and director), Eric K. Chan (our current Chief Executive Officer and director), and Dynacq Healthcare, Inc.  In the suit, the plaintiffs alleged that the Chan family had received improper financial benefits from us.  The plaintiffs sought damages in connection with claims of breach of fiduciary duty, shareholder oppression, constructive trust and conspiracy.  We, through our legal counsel, filed an answer to the original petition, and filed a motion with the Probate Court to dismiss the lawsuit.  The Probate Court granted the motion and dismissed the lawsuit.  On August 19, 2013, the same lawsuit was re-filed in the 151st District Court of Harris County, Texas, in the form of a counterclaim and third party intervention in a lawsuit previously filed by Ella Chan (as Executrix of the Estate of Chiu M. Chan) against Ping Chu for the return of a personal automobile of Chiu M. Chan.  An additional party has joined in the counterclaim and intervention.  We believe the counterclaim and intervention are without merit and intend to vigorously defend ourselves in the suit.
	The Company is routinely involved in litigation and administrative proceedings that are incidental to its business.  Specifically, all judicial review of unsatisfactory determinations of reimbursement amounts due us for our Texas facilities’ fees must be made in the district courts of Travis County, Texas in what can often be a lengthy procedure.

Concentrations_of_Credit_Risk_

Concentrations of Credit Risk and Fair Value of Financial Instruments	12 Months Ended
	Aug. 31, 2013
Risks and Uncertainties [Abstract]	'
Concentration Risk Disclosure [Text Block]	'
		13	Concentrations of Credit Risk and Fair Value of Financial Instruments
	The Company has financial instruments that are exposed to concentrations of credit risk and consist primarily of cash investments and trade accounts receivable. The Company routinely maintains cash and temporary cash investments at certain financial institutions in amounts substantially in excess of (a) Federal Deposit Insurance Corporation (“FDIC”) and Securities Investor Protection Corporation ("SIPC") insurance limits in the U.S. and (b) Hong Kong Deposit Protection Board (“HKDPB”) insurance limits in Hong Kong.  At August 31, 2013, the Company had cash balances in excess of the FDIC and SIPC limits in the U.S. and HKDPB limits in Hong Kong of $11.9 million. Management believes that these financial institutions are of high quality and the risk of loss is minimal.
	As is customary in the healthcare business, the Company has accounts receivable from various third-party payers. The Company does not request collateral from its customers and continually monitors its exposure for credit losses and maintains allowances for anticipated losses. Gross receivables from third-party payers are normally in excess of 90% of the total receivables at any point in time. The mix of gross receivables as at August 31, 2013 and 2012 are as follows:
			2013		2012
	Workers' compensation		1	%	1	%
	Workers' compensation subject to Medical Dispute Resolution process		84	%	84	%
	Commercial		9	%	9	%
	Medicare / Government		1	%	1	%
	Self-pay		4	%	4	%
	Other		1	%	1	%
			100	%	100	%
	We had one third-party payer (customer) who represented 16% and 14% of our gross receivables as of August 31, 2013 and 2012, respectively.    We had three third-party payers (customers) representing 22%, 11% and 11% of the Company’s gross revenue for the fiscal year ended August 31, 2013.  We had two third-party payers (customers) representing 25% and 10% of the Company’s gross revenue for the fiscal year ended August 31, 2012.  For the fiscal year ended August 31, 2013, approximately 90% of our gross revenues were generated from 5 surgeons. For the fiscal year ended August 31, 2012, approximately 90% of our gross revenues were generated from 7 surgeons.
	The carrying amounts of cash and cash equivalents, current receivables, accounts payable and accrued liabilities approximate fair value due to the short-term nature of these instruments. The carrying amounts of the Company's short-term borrowings at August 31, 2013 and 2012 approximate their fair value.

Industry_Segments_and_Geograph

Industry Segments and Geographic Information	12 Months Ended
	Aug. 31, 2013
Segment Reporting [Abstract]	'
Segment Reporting Disclosure [Text Block]	'
		14	Industry Segments and Geographic Information
	The Industry Segment “U.S. Division” comprises of the Company’s Pasadena facility.  The Company at the present time has the U.S. Division and the Corporate Division.
	Certain previously reported financial information has been reclassified to conform to the current year’s presentation.
	Corporate Division
	The Company closed the Garland facility  on September 30, 2011, and sold it in July 2013. The Company took an impairment charge of approximately $1.1 million during the quarter ended August 31, 2012, based on the sales price negotiated at that time.  An additional loss of $122,975 was taken based on the final sales price during the quarter ended August 31, 2013. The Company continues collection efforts on accounts receivable for procedures conducted at the Garland Facility. While these accounts receivable are fully offset by an allowance for doubtful accounts, any cash collections are reported as revenues when received.
	The Company’s previous operations in China conducted through a wholly owned subsidiary, Dynacq-Huai Bei, ceased in February 2011, were classified as discontinued operations, and were exited completely in August 2012.
	The Company organized Sino Bond to hold and manage investments in Hong Kong.  Sino Bond invests in debt instruments (corporate and municipal) and equity securities in Europe and Asia, including initial public offerings and pre-initial public offerings. The Company invests in various marketable securities.   During the fiscal year ended August 31, 2013, one particular security was called on which the Company had a gain of approximately $2.2 million.  As of August 31, 2013, the balance of these securities is valued at approximately $17.5 million.  During the fiscal years ended August 31, 2013 and 2012, the Company also traded in initial public offerings of equity securities on the Hong Kong Stock Exchange and had a net gain (loss) of $695,008 and $(318,206), respectively.
	The Corporate Division includes interest and other income related to its investments in securities, corporate personnel compensation expenses, and general and administrative expenses.  Such expenses and income are not allocated to our operating division, as they relate to our general corporate activities.
	We generally evaluate performance based on profit or loss from operations before income taxes and non-recurring charges and other criteria.  The accounting policies of the reportable segments are the same as those described in the summary of significant accounting policies.  There are no transfers between segments.
	Summarized financial information concerning the business segments from continuing operations is as follows:
			Year Ended August 31,
			2013		2012
	Revenues from external customers
	Net patient service revenues
	U.S. Division		$	6,057,411	$	5,531,233
	Corporate			—		—
	Consolidated		$	6,057,411	$	5,531,233
	Loss before taxes and discontinued operations
	U.S. Division		$	-3,070,917	$	-4,040,738
	Corporate			-388,418		-2,515,232
	Consolidated		$	-3,459,335	$	-6,555,970
			August 31,
			2013		2012
	Total Assets
	U.S. Division		$	9,924,501	$	8,072,893
	Corporate			31,711,826		32,711,311
	Assets of continuing operations			41,636,327		40,784,204
	Assets of discontinued operations			—		5,401,092
	Consolidated		$	41,636,327	$	46,185,296

Significant_Accounting_Policie1

Significant Accounting Policies (Policies)	12 Months Ended
	Aug. 31, 2013
Equity [Abstract]	'
Business And Organization [Policy Text Block]	'
	Business and Organization
	Dynacq Healthcare, Inc., a Nevada corporation (the “Company”), is a holding company that through its subsidiaries in the United States develops and manages general acute care hospitals that principally provide specialized surgeries.  The Company through its United States subsidiaries owns and operates one general acute care hospital in Pasadena, Texas.  The Company through its subsidiary in Hong Kong invests in debt and equity securities, including short-term investments in initial public offerings and pre-initial public offerings.
	The Company was incorporated under the laws of the State of Nevada in 1992. The Company was reincorporated in Delaware in November 2003 and reincorporated back in Nevada in August 2007.
	U.S. Division
	In the United States, the Company manages and operates one general acute care hospital that principally provides specialized surgeries such as bariatric, orthopedic and neuro-spine surgeries.
	In May 1998, Vista Community Medical Center, L.L.C., a Texas limited liability company, was organized for the purpose of operating a hospital (the "Pasadena facility").  In June 2003, the Pasadena facility was converted to a limited liability partnership. As of August 31, 2013 and 2012, the Company through its subsidiaries had a 98% and 99%, respectively, ownership interest in the Pasadena facility.
	In July 2003, Vista Hospital of Dallas, LLP was organized for the purposes of acquiring and operating a surgical hospital in Garland, Texas (the "Garland facility").  The Company closed the Garland facility in September 2011, and sold it in July 2013.  The Garland facility’s operations for the fiscal years ended August 31, 2013 and 2012 are classified as discontinued operations.
	Corporate Division
	The Company organized Sino Bond Inc. Limited, a Hong Kong corporation (“Sino Bond”) to hold and manage investments in Hong Kong.  Sino Bond invests in debt and equity securities in Europe and Asia, including initial public offerings and pre-initial public offerings.
	The Company’s previous operations in China conducted through a wholly owned subsidiary, Dynacq-Huai Bei, ceased in February 2011, were classified as discontinued operations, and were exited completely in August 2012.
Reclassification, Policy [Policy Text Block]	'
	Reclassification
	Certain previously reported financial information has been reclassified to conform to the current year’s presentation.  The impact of such reclassification was not significant to the prior year’s overall presentation.
Consolidation, Policy [Policy Text Block]	'
	Principles of Consolidation
	The consolidated financial statements include the accounts of the Company and its wholly and majority owned subsidiaries. Intercompany accounts and transactions have been eliminated in consolidation.
Basis of Accounting, Policy [Policy Text Block]	'
	Basis of Presentation
	The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for annual financial information and with the instructions to Form 10-K and Article 3 and 3-A of Regulation S-X. The majority of the Company's expenses are "cost of revenue" items. Costs that could be classified as general and administrative by the Company would include the corporate office costs, which were approximately $5.0 million and $4.7 million for the fiscal years 2013 and 2012, respectively.
Use of Estimates, Policy [Policy Text Block]	'
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The most significant of the Company's estimates is the determination of revenue to recognize for the services the Company provides and the determination of allowances, which includes the contractual allowances and the provision for doubtful accounts. See “Revenue Recognition” below for further discussion. Actual results could differ materially from those estimates used in preparation of these financial statements.
Cash and Cash Equivalents, Policy [Policy Text Block]	'
	Cash and Cash Equivalents
	The Company considers all highly liquid instruments with maturities of three months or less on the date of purchase to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value.
Marketable Securities, Policy [Policy Text Block]	'
	Investments in Available-for-Sale and Trading Securities
	The Company’s investments in debt instruments (corporate and municipal bonds) are recorded at fair value based on quoted market prices that are traded in less active markets or priced using a quoted market price for similar investments or are priced using non-binding market consensus prices that can be corroborated by observable market data (Level 2).  These investments are classified as available-for-sale securities.  These investments are subject to default risk.  Unrealized gains in the fair value are reported in accumulated other comprehensive income, net of related income tax effect.  The Company regularly monitors its investment portfolio for any decline in fair value that is other than temporary and records any such impairment as an impairment loss.  The determination of the gain or loss on the sale of any security is made using the specific identification method.  During the fiscal year ended August 31, 2013, one of these available-for-sale securities with a book cost of $450,500 was called for a gain of $2,199,500.  As of August 31, 2013, the balance of these securities is valued at approximately $17.5 million.
	The Company also invests in initial public offerings of equity securities on the Hong Kong Stock Exchange.  These investments are classified as trading securities, and are carried at fair value as of August 31, 2013 and 2012.  These investments are subject to fluctuations in the market price.  During the fiscal years ended August 31, 2013 and 2012, the Company had a net gain (loss) of $695,008 and $(318,206), respectively, in these securities.
Investments In Real Estates And Notes Payable [Policy Text Block]	'
	Investment in Real Estate and Note Payable
	In October 2012, the Company sold an apartment in Hong Kong, which was purchased in March 2010.  The net proceeds from the sale of the apartment were $1,273,402, after repayment of the associated note payable, resulting in a gain on the sale of $480,108.
	In November 2011 and September 2010, the Company borrowed $116,339 and $65,000 as notes payable from a financial institution at an interest rate of 4.5% and 6%, which notes are to be repaid in 36 and 24 monthly installments, respectively, and are secured by specific equipment purchased at our Pasadena facility.  The $65,000 note payable was fully repaid during the quarter ended November 30, 2012.  The Company paid down $41,308 during the fiscal year ended August 31, 2013, and the current and long-term portions of the notes payable as of August 31, 2013 are $40,256 and $6,744, respectively.
Inventory, Policy [Policy Text Block]	'
	Inventories
	Inventories, consisting primarily of medical supplies, are stated at the lower of cost or market, with cost determined by use of the average cost method.
Property, Plant and Equipment, Policy [Policy Text Block]	'
	Property and Equipment
	Property and equipment are stated at cost. Maintenance and repairs are charged to expense as incurred. Expenditures which extend the physical or economic life of the assets are capitalized and depreciated.
	Depreciation is computed using the straight-line method over the estimated useful lives of the assets ranging from five to 39 years. The Company has classified its assets into three categories. The categories are listed below, along with the useful life for each category.
			Useful Life
	Land			N/A
	Buildings and improvements			39 years
	Equipment, furniture and fixtures			5 years
	The Company also leases equipment under capital leases. Such assets are amortized on a straight-line basis over the lesser of the term of the lease or the remaining useful life of the assets.
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]	'
	Impairment of Long-lived Assets
	The Company evaluates the carrying value of property, plant and equipment and definite-lived assets whenever a change in circumstances indicates that the carrying value may not be recoverable from the undiscounted future cash flows from operations. If an impairment exists, the net book values are reduced to fair values as warranted.
Fair Value of Financial Instruments, Policy [Policy Text Block]	'
	Fair Value of Financial Instruments
	The fair value of financial instruments is estimated based on market trading information, where available.  Absent published market values for an instrument or other assets, management uses observable market data to arrive at its estimates of fair value.  Management believes that the carrying amount of cash and cash equivalents, accounts receivable and accrued liabilities approximate fair value. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.  As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability.  A three-level fair value hierarchy prioritizes the inputs used to measure fair value.  The three levels of inputs used to measure fair value are as follows:
	Level 1	Quoted prices in active markets for identical assets or liabilities.
	Level 2	Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and  liabilities in active markets; quoted price for identical or similar assets and liabilities in markets that are not active; or other input that are observable or can be corroborated by observable market data.
	Level 3	Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.
	The following table summarizes our financial assets and liabilities measured and reported in the Company’s statement of financial position at fair value on a recurring basis as of August 31, 2013, segregated among the appropriate levels within the fair value hierarchy:
			Quoted prices in active			Significant other			Significant
			markets for identical			observable inputs			unobservable
			(Level 1)			(Level 2)			(Level 3)
	Assets
	Investments available-for-sale		$	—		$	17,458,985		$	—
	Trading securities			1,071,346			—			—
	The Company’s investments in Level 1 are in equity stocks at a cost of $1,207,335.  The Company’s investments in Level 2 are in perpetual debt instruments (corporate and municipal bonds) traded on the European markets, at a cost of $7,984,646, are recorded at fair value based on quoted market prices that are traded in less active markets or priced using a quoted market price for similar investments or are priced using non-binding market consensus prices that can be corroborated by observable market data (Level 2), and there has been no change in valuation techniques for these investments (Level 2).
Revenue Recognition, Policy [Policy Text Block]	'
	Revenue Recognition
	Background
	The Company's revenue recognition policy is significant because net patient service revenue is a primary component of its results of operations. Revenue is recognized as services are delivered. The determination of the amount of revenue to be recognized in connection with the Company's services is subject to significant judgments and estimates, which are discussed below.
	Revenue Recognition Policy
	The Company has established billing rates for its medical services which it bills as gross revenue as services are delivered.  Gross billed revenues are then reduced by the Company’s estimate of  allowances, which includes the contractual allowance and the provision for doubtful accounts, to arrive at net patient service revenues.  Net patient service revenues may not represent amounts ultimately collected.  The Company adjusts current period revenue for differences in estimated revenue recorded in prior periods and actual cash collections.
	The following table shows gross revenues and allowances for fiscal years 2013 and 2012:
			2013				2012
	Gross billed charges		$	19,498,962			$	19,619,903
	Allowances			13,441,551				14,088,670
	Net revenue		$	6,057,411			$	5,531,233
	Allowance percentage			69	%			72	%
	The table below sets forth the percentage of our gross patient service revenue by financial class for the fiscal years 2013 and 2012:
			2013				2012
	Workers' Compensation			11	%			11	%
	Commercial			43	%			40	%
	Medicare			28	%			28	%
	Medicaid			1	%			1	%
	Self-Pay			14	%			16	%
	Other			3	%			4	%
	Contractual Allowance
	The Company computes its contractual allowance based on the estimated collections on its gross billed charges.  The Company computes its estimate by taking into account collections received, up to 30 days after the end of the period, for the services performed and also estimating amounts collectible for the services performed within the last six months.
	A significant amount of our net revenue results from Texas workers' compensation claims, which are governed by the rules and regulations of the Texas Department of Workers’ Compensation (“TDWC”) and the workers’ compensation healthcare networks. If our hospital chooses to participate in a network, the amount of revenue that will be generated from workers’ compensation claims will be governed by the network contract.
	For claims arising prior to the implementation of workers’ compensation networks and out of network claims, inpatient and outpatient surgical services are either reimbursed pursuant to the Acute Care In-Patient Hospital Fee Guideline or at a "fair and reasonable" rate for services in which the fee guideline is not applicable.  Starting March 1, 2008, the Texas Workers’ Compensation 2008 Acute Care Hospital Outpatient and Inpatient Facility Fee Guidelines (the “Guidelines”) became effective. Under these Guidelines, the reimbursement amounts are determined by applying the most recently adopted and effective Medicare reimbursement formula and factors; however, if the maximum allowable reimbursement for the procedure performed cannot be calculated using these Guidelines, then reimbursement is determined on a fair and reasonable basis.
	Based on these Guidelines, the reimbursement due the Company for workers’ compensation cases is lower than we previously experienced.  The Company has continued accepting Texas workers’ compensation cases, and has not made any substantial changes in its focus towards such cases.  Our net patient service revenue for Texas workers’ compensation cases as a percentage of gross billings has decreased primarily as a result of lower reimbursement rates for workers’ compensation procedures still being performed.
	Should we disagree with the amount of reimbursement provided by a third-party payer, we are required to pursue the medical dispute resolution (“MDR”) process at the TDWC to request proper reimbursement for services.  From January 2007 to November 2008, the Company had been successful in its pursuit of collections regarding the stop-loss cases pending before the State Office of Administrative Hearings (“SOAH”), receiving positive rulings in over 90% of its claims presented for administrative determination.  A 2007 district court decision upholding our interpretation of the statute as applied to the stop-loss claims was appealed by certain insurance carriers, and on November 13, 2008 the Third Court of Appeals determined that in order for a hospital to be reimbursed at 75% of its usual and customary audited charges for an inpatient admission, the hospital must not only bill at least $40,000, but also show that the admission involved unusually costly and unusually extensive services. Procedurally, the decision means that each case where a carrier raised an issue regarding whether the services provided were unusually costly or unusually extensive would be remanded to either SOAH or MDR for a case-by-case determination of whether the services provided meet these standards.  As a result of the Third Court of Appeals opinion, any stop-loss cases pending at SOAH have been remanded to the TDWC since these cases have not been reviewed or decided by the two-prong standard decided by the Third Court of Appeals.  The SOAH Administrative Law judges determined that the most appropriate location for these cases is the TDWC.
	A petition asking the Texas Supreme Court to review the Third Court of Appeals decision has been denied. Therefore, the Company is bound by the Third Court of Appeals decision.  The Texas Supreme Court’s decision delayed final adjudication in these pending stop-loss cases.  The uncertain outcome in these cases will depend on a very lengthy process.  We anticipate further, lengthy litigation at the Travis County District Courts and the Texas Courts of Appeals. Because of this lengthy process and the uncertainty of recovery in these cases, collection of a material amount of funds in these pending stop-loss cases cannot be anticipated.
	Through August 2013, insurance carriers have voluntarily paid the awards in the decisions and orders issued by SOAH, plus interest, in approximately 180 cases, involving approximately $11 million in claims.  In most of these cases, when the payments were made, the carriers requested refunds of the payments made in the event that the SOAH decisions and orders were reversed on appeal (which they were).  Our request that the TDWC Commissioner enforce the awards which were not voluntarily paid by the carriers was refused in approximately 130 cases.  As a result of the reversal of the SOAH decisions and orders, Texas Mutual Insurance Company and other carriers filed petitions in Travis County district court seeking a refund in cases in which the awards were voluntarily paid.  The district court found in favor of Texas Mutual and the Company was ordered to refund approximately $4.2 million, including prejudgment interest, pending remand for a case-by-case determination of whether the services provided were unusually costly and unusually extensive.  The Company did not object to the reversal and remand of the SOAH decisions and orders, but did object to the judgments ordering refunds and those judgments were appealed to the Third Court of Appeals.  As part of the appeals, the Company deposited the amounts that were ordered to be refunded as cash deposits into the registry of the court in order to stay execution of the judgments ordering refunds.  On June 6, 2013, the judgments ordering refunds were reversed by the Court of Appeals.  The Court of Appeals held that if Texas Mutual wants a refund, it must pursue the refund demand administratively through the TDWC rather than through the district courts.  Texas Mutual filed a motion for rehearing with the Court of Appeals which ultimately was denied.  The Vista entities have filed motions in all 47 cases with the district court asking that the district clerk be ordered to release the deposited funds to the Vista entities.  These motions are pending.  In addition, Texas Mutual filed three additional petitions in district court for cases that were left out of the original 47.  The court granted Texas Mutual’s petitions and ordered the Vista entities to refund approximately $300,000, including prejudgment interest to Texas Mutual.  These judgments were granted before the Court of Appeals reversed the district court’s original judgments.  These three cases have been appealed to the Court of Appeals and the funds ordered refunded have been deposited with the district clerk.  The Company expects that in due course these three additional judgments will be reversed.  If the Court of Appeals’ decision holds, all of the money deposited into the registry of the court will be refunded to the Company.  At this time, Texas Mutual has not decided whether to file a petition for review with the Supreme Court of Texas.  Should Texas Mutual be successful in reversing the Court of Appeals’ decision, we anticipate that similar motions requesting remand and a refund for awards voluntarily paid will be filed and will likely be granted by the 345th Judicial District Court of Travis County, Texas.   If and when these additional motions are granted, the Company will be ordered to refund an additional $8.1 million, not including prejudgment interest.  As of August 31, 2013, the Company has accrued this amount of $8.1 million, and an additional amount of $2.2 million in interest payable, as accrued liabilities.  If the Court of Appeals’ decision holds, we do not anticipate that any other carriers will pursue refund demands through district court but instead will pursue them administratively through TDWC.   The cases in which the SOAH decisions and orders were reversed have been or are being remanded to TDWC for determinations of whether the services provided were unusually costly and unusually extensive. Voluntary payments made pursuant to the Decisions and Orders are premature payments by the carriers and may be ordered to be refunded.  Once the Company is given the opportunity to present its evidence regarding whether the services provided were unusually costly and unusually extensive, the Company anticipates that it will prevail in many of the underlying stop-loss fee disputes and that payments refunded to the carriers will be recaptured.
	Due to the uncertainties associated with these stop-loss fee dispute cases, the Company recognized increases in the contractual allowance at our Pasadena facility of $10,254,990 and $149,875 during fiscal years 2011 and 2013, respectively, (and an additional amount of $779,583 and $136,542 in the contractual allowance during fiscal years 2011 and 2013, respectively, at our Garland facility, which is classified as discontinued operations), and interest expense of $1,751,478, $547,366 and $548,113 for the fiscal years 2011, 2012 and 2013, respectively, at our Pasadena facility (and an additional interest expense of $132,339, $42,954 and $44,829 for the fiscal years 2011, 2012 and 2013, respectively, at our Garland facility).
	Claims regarding payment for ambulatory surgical center and hospital outpatient services remain pending at the TDWC.  It is expected that these claims will be adjudicated at SOAH and possibly in the Texas district and appellate courts. The basis for reimbursement for these services made the subject of these pending cases is the determination of “fair and reasonable” charges.  In 2007, we received unfavorable rulings from SOAH in all of our appeals of unfavorable decisions related to services provided in 2001 and 2002.  The 179 cases, which were appealed to the Travis County district courts, challenged the constitutionality of the relevant statutory language.  The Company received an unfavorable ruling in its lead case in March 2009, which ruling was appealed to and was upheld by the Third Court of Appeals on August 26, 2010.  The Texas Supreme Court denied a petition asking for review of the Third Court of Appeals decision.  The unfavorable interpretation by the Texas Courts of Appeal in our lead case negatively affects the recovery of additional reimbursement, not only in the lead case, but in the remaining 178 pending cases.  Consequently, the Company is bound by the Third Court of Appeals’ ruling that interprets the applicable statute and fee guideline to require that the amount that will be paid to a provider must not only be at a “fair and reasonable rate” but also must “ensure the quality of medical care” and “achieve effective cost control” and be the same or less than that charged to others with an equivalent standard of living.  This ruling will impact cases in which a fee guideline was not applicable, specifically all pending cases involving ambulatory surgical services provided from 2001 through 2004 as well as all pending cases involving hospital outpatient services provided prior to March 1, 2008, when the Guidelines took effect.  Since the Third Court of Appeals’ unfavorable ruling, collection, if any, in these cases depends on the Company’s ability to establish the criteria in this ruling. The Company was given the opportunity to establish the criteria in approximately 80 cases, which were set for hearing on the merits from March through May 2012 and was unsuccessful.  Additionally, there are several thousand ambulatory surgical center and hospital outpatient cases pending at SOAH which will be heard beginning in January, 2014.  Settlement offers have been made in the vast majority of these cases and the Company has been successful in settling many of the cases in which offers were made.  Even so, it is likely that hundreds, if not more than a thousand, of these cases may go to hearing at SOAH at which the Company will have the opportunity to continue to establish the criteria in the cases still pending at SOAH during the 2014 fiscal year.
	Due to the uncertainties regarding the accounts receivable in the MDR process, the 2008 and 2010 Third Court of Appeals’ opinions and our legal counsel’s advice that settlements with insurance carriers in stop-loss cases have virtually stopped, the Company had fully reserved all accounts receivable related to the MDR process as of August 31, 2008.  The Company is in active settlement negotiations with insurance carriers for ambulatory surgical center and hospital outpatient cases.  Any monies collected for these MDR accounts receivable will be recorded as current period’s net patient service revenues.
	Provision for Doubtful Accounts
	Although outcomes vary, our policy is to attempt to collect amounts due from patients, including co-payments and deductibles due from patients with insurance, at the time of service while complying with all federal and state laws and regulations. In non-emergency circumstances or for elective procedures and services, it is our policy to verify insurance prior to a patient being treated; however, there are various exceptions that can occur.
	The Company computes its allowances based on the estimated collections on its gross billed charges.  The Company computes its estimate of allowance, which is a combination of contractual allowance and provision for doubtful accounts, by taking into account collections received, up to 30 days after the end of the period, for the services performed and also estimating amounts collectible for the services performed within the last six months.
	Accounts receivable represent net receivables for services provided by the Company.  At each balance sheet date management reviews the accounts receivable for collectibility and provides full allowance reserves for any accounts receivable deemed uncollectible.
	The allowances stated as a percentage of gross receivables at the balance sheet dates is larger than the allowance percentage used to reduce gross billed charges due to the application of partial cash collections to the outstanding gross receivable balances, without any adjustment being made to the allowances. The allowance amounts netted against gross receivables are not adjusted until such time as the final collections on an individual receivable are recognized.
	The focal point of our business is providing patient care services, including complex orthopedic and bariatric procedures. The Company pursues optimal reimbursement from third-party payers for these services. In some instances, we do not have contractual arrangements with third-party payers which provide for “prompt payment” which may result in additional time to collect the expected reimbursement.
	The collection process may also be extended due to our efforts to obtain all optimal reimbursement available to the Company. Specifically, for medical services provided to injured workers, the Company may initially receive reimbursement that may not be within the fee guidelines or regulatory guidelines mandating reimbursement. The Company reviews and pursues those particular claims that are determined to warrant additional reimbursement pursuant to the fee or regulatory guidelines. The Company's pursuit of additional reimbursement amounts that it believes are due under fee or regulatory guidelines may be accomplished through established dispute resolution procedures with applicable regulatory authorities.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	'
	Stock Based Compensation
	The Company estimates the fair value of stock options granted using the Black-Scholes option pricing model. The fair value for awards that are expected to vest is then amortized on a straight-line basis over the requisite service period of the award, which is generally the option vesting term. The amount of expense attributed is based on estimated forfeiture rate, which is updated based on actual forfeitures as appropriate. This option pricing model requires the input of highly subjective assumptions, including the expected volatility of our common stock, pre-vesting forfeiture rate and an option’s expected life. The financial statements include amounts that are based on the Company’s best estimates and judgments.
Advertising Costs, Policy [Policy Text Block]	'
	Advertising Costs
	Advertising and marketing costs in the amounts of $125,000 and $162,000 for the fiscal years ended August 31, 2013 and 2012, respectively, were expensed as incurred.  In fiscal year 2012, the Company reversed $870,000 of marketing costs that were expensed and accrued for in fiscal year 2011, since the amounts were determined to be not payable.
Income Tax, Policy [Policy Text Block]	'
	Income Taxes
	The Company uses the liability method in accounting for income taxes. Under this method, deferred tax liabilities or assets are determined based on differences between the income tax basis and the financial reporting basis of assets and liabilities and are measured using the enacted tax rates and laws that are expected to be in effect when the differences are expected to reverse.  If the Company is uncertain about its ability to recognize benefit from net operating losses, it records a valuation allowance against deferred tax assets.
Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]	'
	Noncontrolling Interest
	The equity of minority investors (minority investors are generally physician groups and other healthcare providers that perform surgeries at the Company's facilities) in certain subsidiaries of the Company is reported on the consolidated balance sheets as noncontrolling interest. Noncontrolling interest reported in the consolidated income statements reflect the respective interests in the income or loss of the limited partnerships or limited liability companies attributable to the minority investors (equity interests ranged from 1% to 1.75% during the fiscal year ended August 31, 2013).
	The following table sets forth the activity in the noncontrolling interest liability account for the fiscal years ended August 31, 2013 and 2012:
	Balance August 31, 2011		$	63,617
	Loss allocated to noncontrolling interest holders			-47,358
	Capital contributions from/distributions to new noncontrolling interest holders, net			50,000
	Balance August 31, 2012			66,259
	Loss allocated to noncontrolling interest holders			-2,836
	Balance August 31, 2013		$	63,423
Earnings Per Share, Policy [Policy Text Block]	'
	Earnings (Loss) per Share
	Earnings (loss) per share has been computed using the weighted average number of common shares outstanding during the period. Diluted net income (loss) per share has been calculated to give effect to the dilutive effect of common stock equivalents consisting of stock options in years in which the Company has income. The calculation of dilutive shares outstanding excludes 1,096,475 options and 2,790,566 options outstanding as of August 31, 2013 and 2012, respectively, because their effect is antidilutive.
Foreign Currency Transactions and Translations Policy [Policy Text Block]	'
	Foreign Currency Translation
	The functional currency of the Company as a whole is the U.S. Dollar.  The Company has designated the U.S. Dollar as the functional currency for Sino Bond in Hong Kong. The effects of foreign currency exchange adjustments are included as a component of Rent and Other Income in the Consolidated Statements of Operations.
New Accounting Pronouncements, Policy [Policy Text Block]	'
	Recent Accounting Pronouncements
	No recent accounting pronouncements or other authoritative guidance has been issued that management considers likely to have a material impact on our consolidated financial statements.

Significant_Accounting_Policie2

Significant Accounting Policies (Tables)	12 Months Ended
	Aug. 31, 2013
Accounting Policies [Abstract]	'
Schedule Of Property Plant And Equipment Estimated Useful Life [Table Text Block]	'
	The categories are listed below, along with the useful life for each category.
		Useful Life
	Land		N/A
	Buildings and improvements		39 years
	Equipment, furniture and fixtures		5 years
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	'
	The following table summarizes our financial assets and liabilities measured and reported in the Company’s statement of financial position at fair value on a recurring basis as of August 31, 2013, segregated among the appropriate levels within the fair value hierarchy:
		Quoted prices in active			Significant other			Significant
		markets for identical			observable inputs			unobservable
		(Level 1)			(Level 2)			(Level 3)
	Assets
	Investments available-for-sale	$	—		$	17,458,985		$	—
	Trading securities		1,071,346			—			—
Percentage Of Gross Patient Service Revenue By Financial Class [Table Text Block]	'
	The following table shows gross revenues and allowances for fiscal years 2013 and 2012:
		2013				2012
	Gross billed charges	$	19,498,962			$	19,619,903
	Allowances		13,441,551				14,088,670
	Net revenue	$	6,057,411			$	5,531,233
	Allowance percentage		69	%			72	%
Schedule Of Gross Revenues And Contractual Allowances [ Table Text Block]	'
	The table below sets forth the percentage of our gross patient service revenue by financial class for the fiscal years 2013 and 2012:
		2013				2012
	Workers' Compensation		11	%			11	%
	Commercial		43	%			40	%
	Medicare		28	%			28	%
	Medicaid		1	%			1	%
	Self-Pay		14	%			16	%
	Other		3	%			4	%
Schedule Of Movement In Minority Interest [Table Text Block]	'
	The following table sets forth the activity in the noncontrolling interest account for the fiscal years ended August 31, 2013 and 2012:
	Balance August 31, 2011	$	63,617
	Loss allocated to noncontrolling interest holders		-47,358
	Capital contributions from/distributions to new noncontrolling interest holders, net		50,000
	Balance August 31, 2012		66,259
	Loss allocated to noncontrolling interest holders		-2,836
	Balance August 31, 2013	$	63,423

Property_and_Equipment_Tables

Property and Equipment (Tables)	12 Months Ended
	Aug. 31, 2013
Property, Plant and Equipment [Abstract]	'
Property, Plant and Equipment [Table Text Block]	'
	At August 31, property and equipment consisted of the following:
		2013		2012
	Land	$	497,110	$	497,110
	Buildings and improvements		8,989,115		8,989,115
	Equipment, furniture and fixtures (including equipment under capital lease of		8,528,872		10,058,232
	$585,450 and $470,091, respectively)
			18,015,097		19,544,457
	Less accumulated depreciation and amortization (including amortization		-11,691,440		-12,888,637
	for equipment under capital lease of $449,860 and $340,461, respectively)
	Net property and equipment	$	6,323,657	$	6,655,820

Discontinued_Operations_Tables

Discontinued Operations (Tables)	12 Months Ended
	Aug. 31, 2013
Discontinued Operations And Disposal Groups [Abstract]	'
Schedule of Disposal Groups, Including Discontinued Operations, Income Statement, Balance Sheet and Additional Disclosures [Table Text Block]	'
	The following is a summary of financial information related to our discontinued operations for the fiscal years ended August 31, 2013 and 2012:
	Discontinued Operations
		Year Ended August 31, 2013						Year Ended August 31, 2012
		Garland		China		Total		Garland		China		Total
		Facility		Operations				Facility		Operations
	Net patient service revenue	$	451,965	$	—	$	451,965	$	397,278	$	—	$	397,278
	Costs and expenses:
	Compensation and benefits		32,415		—		32,415		181,693		22,644		204,337
	Medical services and supplies		-8,301		—		-8,301		235,977		—		235,977
	Other operating expenses		158,061		—		158,061		957,090		-363,148		593,942
	Asset impairment charge		—		—		—		1,058,056		—		1,058,056
	Depreciation and amortization		—		—		—		—		82,353		82,353
	Total costs and expenses		182,175		—		182,175		2,432,816		-258,151		2,174,665
	Operating income (loss)		269,790		—		269,790		-2,035,538		258,151		-1,777,387
	Other income (expense), net		4,600		—		4,600		304,673		77,730		382,403
	Income (loss) before income taxes		274,390		—		274,390		-1,730,865		335,881		-1,394,984
	Benefit for income taxes		—		—		—		—		—		—
	Income (loss) on discontinued operations, net of taxes		274,390		—		274,390		-1,730,865		335,881		-1,394,984
	Loss on disposal of discontinued assets		-122,975		—		-122,975		—		-229,201		-229,201
	Benefit for income taxes		—		—		—		—		—		—
	Loss on disposal of discontinued operations, net of taxes		-122,975		—		-122,975		—		-229,201		-229,201
	Total income (loss) on discontinued operations,	$	151,415	$	—	$	151,415	$	-1,730,865	$	106,680	$	-1,624,185
	net of taxes
		August 31, 2013						August 31, 2012
		Garland		China		Total		Garland		China		Total
		Facility		Operations				Facility		Operations
	Current assets	$	—	$	—	$	—	$	—	$	—	$	—
	Property and equipment, net		—		—		—		5,401,092		—		5,401,092
	Total assets	$	—	$	—	$	—	$	5,401,092	$	—	$	5,401,092
	Current liabilities:
	Accounts payable and accrued liabilities	$	—	$	—	$	—	$	—	$	—	$	—
	Total liabilities	$	—	$	—	$	—	$	—	$	—	$	—

Notes_payable_Tables

Notes payable (Tables)	12 Months Ended
	Aug. 31, 2013
Debt Disclosure [Abstract]	'
Schedule of Debt [Table Text Block]	'
	At August 31, notes payable consisted of the following:
		2013		2012
	Note payable secured by the apartment in Hong Kong.	$	—	$	1,091,615
	The Company obtained an 18-year mortgage loan of $1,245,775
	from a financial institution, with a variable interest rate at the lower of 3-month
	Hang Seng Interbank Offered Rates plus 0.7% or 2.9% below the Hong Kong
	Dollar best lending rate quoted by the financial institution. In fiscal year 2013,
	the apartment was sold, and the related note payable was also paid off.
	Notes payable for $116,339 and $65,000 for purchases of equipment for the		47,000		88,307
	Pasadena facility at an interest rate of 4.5% and 6%, secured by the said
	equipment.
	Total		47,000		1,179,922
	Less: Current portion		-40,256		-105,735
	Long-term portion	$	6,744	$	1,074,187

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Aug. 31, 2013
Income Tax Disclosure [Abstract]	'
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]	'
	The provision (benefit) for income taxes consisted of the following:
		Year Ended August 31,
		2013		2012
	Current tax (benefit) expense:
	Federal	$	–	$	–
	State		–		–
	Total current		–		–
	Deferred tax (benefit) expense:
	Federal		–		4,018,699
	State		–		–
	Total deferred		–		4,018,699
	Total income tax expense	$	–	$	4,018,699
Schedule Of Component Of Provision Benefit For Deferred Income Taxes [Table Text Block]	'
	The components of the provision (benefit) for deferred income taxes at August 31 were as follows:
		2013		2012
	Applicable to:
	Net operating loss carryforward	$	-1,611,973	$	-4,941,754
	Differences between revenues and expenses recognized for		246,396		2,172,058
	federal income tax and financial reporting purposes
	Difference in method of computing depreciation for tax and		26,981		49,061
	financial reporting purposes
	Changes in valuation allowance		1,338,596		6,739,334
	Deferred income tax expense	$	–	$	4,018,699
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	'
	Significant components of the Company's deferred tax liabilities and assets were as follows at August 31, 2013:
		Current		Noncurrent
	Deferred tax liabilities:
	Depreciation	$	–	$	-207,396
	Deferred tax assets:
	Net operating loss carryforward		–		9,439,548
	Revenue and expense differences		13,157		3,580,862
	Allowance for uncollectible accounts		513,456		–
	Other		-166,758		-29,869
	Valuation allowance		-359,855		-12,783,145
	Net deferred tax asset (liability)	$	–	$	–
	Significant components of the Company's deferred tax liabilities and assets were as follows at August 31, 2012:
		Current		Noncurrent
	Deferred tax liabilities:
	Depreciation	$	–	$	-180,415
	Deferred tax assets:
	Net operating loss carryforward		–		7,827,575
	Revenue and expense differences		54,664		3,342,010
	Allowance for uncollectible accounts		513,456		–
	Asset impairment		370,320		–
	Other		-166,758		43,551
	Valuation allowance		-771,682		-11,032,721
	Net deferred tax asset (liability)	$	–	$	–
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	'
	A reconciliation of the benefit for income taxes with amounts determined by applying the statutory federal income tax rate to income before income taxes and noncontrolling interests is as follows:
		Year Ended August 31,
		2013		2012
	Benefit for income taxes computed using the statutory rate of 35%	$	-1,210,767	$	-2,294,590
	Noncontrolling interest in loss of consolidated subsidiaries		993		16,575
	Non-deductible expenses		-128,822		-442,620
	Changes in valuation allowance		1,338,596		6,739,334
	Expense for income taxes	$	—	$	4,018,699

Stockholders_Equity_and_Stock_1

Stockholders' Equity and Stock Option Plan (Tables)	12 Months Ended
	Aug. 31, 2013
Stockholders Equity And Stock Option Plan [Abstract]	'
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	'
	The following table summarizes the stock option activities for the fiscal year ended August 31, 2013 (share amounts in thousands):
						Weighted Average
						Option Exercise
			Shares			Price Per Share
	Outstanding, August 31, 2011			2,206		$	2.41
	Granted			1,450			1.03
	Exercised			—			—
	Expired or canceled			-865			1.68
	Outstanding, August 31, 2012			2,791			1.92
	Granted			—			—
	Exercised			—			—
	Expired or canceled			-1,694			1.74
	Outstanding, August 31, 2013			1,097			2.21
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]	'
	The following summarizes information related to stock options outstanding as of August 31, 2013, and related weighted average price and life information:
				Options Outstanding					Options Exercisable
	Exercise Prices			Number of			Weighted Average		Number of Shares
				Shares			Remaining Contractual
							Life (Years)
				(Share Amounts In Thousands)
	$	1.1			250			8.4		63
	$	1.86			660			7.9		330
	$	4.9			187			1.3		187
	Total				1,097			6.8		580
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]	'
	The fair value of the stock-based awards in fiscal year 2012 was $754,224 and was estimated using the Black-Scholes model with the following weighted average assumptions:
			Year Ended August 31, 2012
	Estimated fair value per share		$	0.52
	Expected life (years)			4.1
	Risk free interest rate			0.79	%
	Volatility			78	%
	Dividend yield			—

Net_Income_Loss_Per_Share_Tabl

Net Income (Loss) Per Share (Tables)	12 Months Ended
	Aug. 31, 2013
Earnings Per Share [Abstract]	'
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	'
	The following table presents the computation of basic and diluted earnings (loss) per common share attributable to the Company:
		Year Ended August 31,
		2013		2012
	Basic and diluted earnings (loss):
	Numerator:
	Loss from continuing operations	$	-3,459,335	$	-10,574,669
	Less: Net loss attributable to noncontrolling interest		2,836		47,358
	Loss from continuing operations attributable to Dynacq Healthcare, Inc.		-3,456,499		-10,527,311
	Income (loss) from discontinued operations, net of income taxes		151,415		-1,624,185
	Net loss attributable to Dynacq Healthcare, Inc.	$	-3,305,084	$	-12,151,496
	Denominator:
	Basic and diluted average common shares outstanding		14,543,626		14,489,780
	Basic and diluted earnings (loss) per common share:
	Loss from continuing operations attributable to Dynacq Healthcare, Inc.	$	-0.24	$	-0.73
	Income (loss) from discontinued operations, net of income taxes		0.01		-0.12
	Net loss attributable to Dynacq Healthcare, Inc.	$	-0.23	$	-0.85

Other_Comprehensive_Income_Los1

Other Comprehensive Income (Loss) and Accumulated Other Comprehensive Income (Tables)	12 Months Ended
	Aug. 31, 2013
Equity [Abstract]	'
Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]	'
	The following table presents information about items reclassified out of accumulated other comprehensive income (loss) by component for the fiscal year ended August 31, 2013 (net of tax):
		Change in Foreign		Change in Fair		Accumulated
		Currency		Value of Available-		Other
		Translation		for-Sale Securities		Comprehensive
		Adjustment				Income (Loss)
	Balance as of August 31, 2012	$	8,196	$	8,411,128	$	8,419,324
	Other comprehensive income before		—		3,170,706		3,170,706
	reclassifications
	Amounts reclassified from accumulated		-8,196		-2,199,500		-2,207,696
	other comprehensive income
	Net current-period other comprehensive		-8,196		971,206		963,010
	income (loss)
	Balance as of August 31, 2013	$	—	$	9,382,334	$	9,382,334
Reclassification To Net Income Out Of Accumulated Other Comprehensive Income Loss [Table Text Block]	'
	The following table presents a subtotal for each significant reclassification to net income out of accumulated other comprehensive income (loss) and the line item affected in the consolidated statement of operations during the fiscal year ended August 31, 2013:
	Details about accumulated other comprehensive		Amount reclassified	Affected line item in the
	income (loss) components		from accumulated	statement where net
			other comprehensive	income is presented
			income
	Gain on foreign currency translation adjustment	$	12,610	Rent and other income
	Tax provision		-4,414	Accrued liabilities
		$	8,196
	Gain on call of available-for-sale securities	$	2,199,500	Rent and other income
	Tax provision		—
		$	2,199,500
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	'
	The components of accumulated other comprehensive income were as follows:
		August 31, 2013		August 31, 2012
	Foreign currency translation adjustment, net of taxes of $-0- and	$	—	$	8,196
	$4,414, respectively
	Change in valuation of investment available-for-sale, net of taxes of $-0- and		9,382,334		8,411,128
	$-0-, respectively
	Total accumulated other comprehensive income, net of taxes of $-0- and	$	9,382,334	$	8,419,324
	$4,414, respectively

Accrued_Liabilities_Tables

Accrued Liabilities (Tables)	12 Months Ended
	Aug. 31, 2013
Payables and Accruals [Abstract]	'
Schedule of Accrued Liabilities [Table Text Block]	'
	Accrued liabilities at August 31 is as follows:
		2013		2012
	MDR stop-loss cases accrual, including accrued interest	$	10,231,033	$	9,548,602
	Marketing fees liability		300,000		300,000
	Payroll and related taxes		306,450		389,713
	Property taxes		189,202		339,527
	Year-end accruals of expenses and other		818,632		1,185,520
	Total accrued liabilities	$	11,845,317	$	11,763,362

Concentrations_of_Credit_Risk_1

Concentrations of Credit Risk and Fair Value of Financial Instruments (Tables)	12 Months Ended
	Aug. 31, 2013
Risks and Uncertainties [Abstract]	'
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]	'
	The mix of gross receivables as at August 31, 2013 and 2012 are as follows:
		2013		2012
	Workers' compensation	1	%	1	%
	Workers' compensation subject to Medical Dispute Resolution process	84	%	84	%
	Commercial	9	%	9	%
	Medicare / Government	1	%	1	%
	Self-pay	4	%	4	%
	Other	1	%	1	%
		100	%	100	%

Industry_Segments_and_Geograph1

Industry Segments and Geographic Information (Tables)	12 Months Ended
	Aug. 31, 2013
Segment Reporting [Abstract]	'
Reconciliation of Revenue from Segments to Consolidated [Table Text Block]	'
	Summarized financial information concerning the business segments from continuing operations is as follows:
		Year Ended August 31,
		2013		2012
	Revenues from external customers
	Net patient service revenues
	U.S. Division	$	6,057,411	$	5,531,233
	Corporate		—		—
	Consolidated	$	6,057,411	$	5,531,233
	Loss before taxes and discontinued operations
	U.S. Division	$	-3,070,917	$	-4,040,738
	Corporate		-388,418		-2,515,232
	Consolidated	$	-3,459,335	$	-6,555,970
Reconciliation of Assets from Segment to Consolidated [Table Text Block]	'
		August 31,
		2013		2012
	Total Assets
	U.S. Division	$	9,924,501	$	8,072,893
	Corporate		31,711,826		32,711,311
	Assets of continuing operations		41,636,327		40,784,204
	Assets of discontinued operations		—		5,401,092
	Consolidated	$	41,636,327	$	46,185,296

Significant_Accounting_Policie3

Significant Accounting Policies (Details)	12 Months Ended
	Aug. 31, 2013
Land [Member]	'
Estimated useful lives of assets	'
Property, Plant and Equipment, Useful Life	'0 years
Building and Improvements [Member]	'
Estimated useful lives of assets	'
Property, Plant and Equipment, Useful Life	'39 years
Equipment, furniture and fixtures [Member]	'
Estimated useful lives of assets	'
Property, Plant and Equipment, Useful Life	'5 years

Significant_Accounting_Policie4

Significant Accounting Policies (Details 1) (Fair Value Measurements Recurring [Member], USD $)	Aug. 31, 2013
Quoted prices in active markets for identical Level 1 [Member]	'
Assets	'
Investments available-for-sale	$0
Trading Securities	1,071,346
Significant other observable inputs Level 2 [Member]	'
Assets	'
Investments available-for-sale	17,458,985
Trading Securities	0
Significant unobservable Level 3 [Member]	'
Assets	'
Investments available-for-sale	0
Trading Securities	$0

Significant_Accounting_Policie5

Significant Accounting Policies (Details 2) (USD $)	12 Months Ended
	Aug. 31, 2013	Aug. 31, 2012
Gross Revenues And Contractual Allowances [Line Items]	'	'
Gross billed charges	$19,498,962	$19,619,903
Allowances	13,441,551	14,088,670
Net revenue	$6,057,411	$5,531,233
Allowance percentage	69.00%	72.00%

Significant_Accounting_Policie6

Significant Accounting Policies (Details 3)	12 Months Ended
	Aug. 31, 2013	Aug. 31, 2012
Product Information [Line Items]	'	'
Concentration Risk, Percentage	100.00%	100.00%
Third-Party Payor [Member] | Workers' compensation [Member]	'	'
Product Information [Line Items]	'	'
Concentration Risk, Percentage	11.00%	11.00%
Third-Party Payor [Member] | Commercial [Member]	'	'
Product Information [Line Items]	'	'
Concentration Risk, Percentage	43.00%	40.00%
Third-Party Payor [Member] | Medicare [Member]	'	'
Product Information [Line Items]	'	'
Concentration Risk, Percentage	28.00%	28.00%
Third-Party Payor [Member] | Medicaid [Member]	'	'
Product Information [Line Items]	'	'
Concentration Risk, Percentage	1.00%	1.00%
Self-Pay [Member]	'	'
Product Information [Line Items]	'	'
Concentration Risk, Percentage	14.00%	16.00%
Other Credit Derivatives [Member] | Third-Party Payor [Member]	'	'
Product Information [Line Items]	'	'
Concentration Risk, Percentage	3.00%	4.00%

Significant_Accounting_Policie7

Significant Accounting Policies (Details 4) (USD $)	12 Months Ended
	Aug. 31, 2013	Aug. 31, 2012
Movement In Minority Interest [Line Items]	'	'
Beginning Balance, Noncontrolling interest	$66,259	$63,617
Loss allocated to noncontrolling interest holders	-2,836	-47,358
Capital contributions from/distributions to new noncontrolling interest holders, net	'	50,000
Ending Balance, Noncontrolling interest	$63,423	$66,259

Significant_Accounting_Policie8

Significant Accounting Policies (Details Textual) (USD $)	0 Months Ended		1 Months Ended		3 Months Ended		12 Months Ended			23 Months Ended
	Jun. 06, 2013	Nov. 13, 2008	Nov. 30, 2011	Sep. 30, 2010	Nov. 30, 2012	31-May-12	Aug. 31, 2013	Aug. 31, 2012	Aug. 31, 2011	Nov. 30, 2008
						Cases	Cases
Significant Accounting Policies [Line Items]	'	'	'	'	'	'	'	'	'	'
Corporate Office Costs	'	'	'	'	'	'	$5,000,000	$4,700,000	'	'
Available For Sale Securities Noncurrent	'	'	'	'	'	'	17,458,985	16,828,886	'	'
Secured Debt	'	'	116,339	65,000	'	'	116,339	65,000	'	'
Notes Payable Secured By Equipment At Interest Rate	'	'	4.50%	6.00%	'	'	'	'	'	'
Notes Payable Repayment Period	'	'	'36 months	'24 months	'	'	'	'	'	'
Repayments Of Notes Payable Secured By Equipment	'	'	'	'	'	'	41,308	'	'	'
Notes Payable Secured By Equipment Amount Outstanding Current	'	'	'	'	'	'	40,256	'	'	'
Notes Payable Secured By Equipment Amount Outstanding Non Current	'	'	'	'	'	'	6,744	'	'	'
Receivables Collection Period	'	'	'	'	'	'	'30 days	'	'	'
Percentage Of Claims With Positive Rulings	'	'	'	'	'	'	'	'	'	90.00%
Reimbursement Of Usual And Customary Audited Charges Percentage	'	75.00%	'	'	'	'	'	'	'	'
Minimum Billing Requirement For Reimbursement	'	40,000	'	'	'	'	'	'	'	'
Number Of Cases Awards Paid By Insurance Carriers	'	'	'	'	'	'	180	'	'	'
Awards Paid By Insurance Carriers Amount	'	'	'	'	'	'	11,000,000	'	'	'
Number Of Cases In Which Awards Not Paid By Insurance Carriers	'	'	'	'	'	'	130	'	'	'
Loss Contingency Refund Of Voluntary Award Including Prejudgment Interest	300,000	'	'	'	'	'	4,200,000	'	'	'
Loss Contingency Amount Of Refund In Case Of Additional Motions Granted	'	'	'	'	'	'	8,100,000	'	'	'
Loss Contingency, Pending Claims, Number	'	'	'	'	'	'	179	'	'	'
Loss Contingency Pending Claims Number Negatively Affecting Recovery Of Additional Reimbursement	'	'	'	'	'	'	178	'	'	'
Number Of Cases With Opportunity To Establish Criteria	'	'	'	'	'	80	'	'	'	'
Marketing and Advertising Expense, Total	'	'	'	'	'	'	125,000	162,000	'	'
Marketing Costs Expensed And Accrued	'	'	'	'	'	'	'	-870,000	870,000	'
Available For Sale Securities Book Value	'	'	'	'	'	'	450,500	'	'	'
Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Net of Tax	'	'	'	'	'	'	-2,199,500	'	'	'
Proceeds From Sale Of Real Estate Heldforinvestment	'	'	'	'	'	'	2,365,017	0	'	'
Gains Losses On Sales Of Investment Real Estate	'	'	'	'	'	'	480,108	0	'	'
Repayments of Secured Debt	'	'	'	'	65,000	'	'	'	'	'
Interest Payable	'	'	'	'	'	'	8,100,000	'	'	'
Additional Interest Payable Current And Noncurrent	'	'	'	'	'	'	2,200,000	'	'	'
Employee Stock Option [Member]	'	'	'	'	'	'	'	'	'	'
Significant Accounting Policies [Line Items]	'	'	'	'	'	'	'	'	'	'
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount	'	'	'	'	'	'	1,096,475	2,790,566	'	'
Maximum [Member]	'	'	'	'	'	'	'	'	'	'
Significant Accounting Policies [Line Items]	'	'	'	'	'	'	'	'	'	'
Property, Plant and Equipment, Useful Life	'	'	'	'	'	'	'39 years	'	'	'
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners	'	'	'	'	'	'	2.00%	'	'	'
Minimum [Member]	'	'	'	'	'	'	'	'	'	'
Significant Accounting Policies [Line Items]	'	'	'	'	'	'	'	'	'	'
Property, Plant and Equipment, Useful Life	'	'	'	'	'	'	'5 years	'	'	'
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners	'	'	'	'	'	'	1.75%	'	'	'
HONG KONG [Member]	'	'	'	'	'	'	'	'	'	'
Significant Accounting Policies [Line Items]	'	'	'	'	'	'	'	'	'	'
Trading Securities Realized Gain Loss	'	'	'	'	'	'	695,008	-318,206	'	'
Proceeds From Sale Of Real Estate Heldforinvestment	'	'	'	'	'	'	1,273,402	'	'	'
Pasadena Facility [Member]	'	'	'	'	'	'	'	'	'	'
Significant Accounting Policies [Line Items]	'	'	'	'	'	'	'	'	'	'
Noncontrolling Interest, Ownership Percentage by Parent	'	'	'	'	'	'	98.00%	99.00%	'	'
Increase In Facility Contractual Allowance	'	'	'	'	'	'	149,875	'	10,254,990	'
Increase In Interest Expense	'	'	'	'	'	'	548,113	547,366	1,751,478	'
Garland Facility [Member]	'	'	'	'	'	'	'	'	'	'
Significant Accounting Policies [Line Items]	'	'	'	'	'	'	'	'	'	'
Additional Loss Contractual Allowance	'	'	'	'	'	'	136,542	'	779,583	'
Facility Additional Interest Expense	'	'	'	'	'	'	44,829	42,954	132,339	'
Investments Level1 [Member]	'	'	'	'	'	'	'	'	'	'
Significant Accounting Policies [Line Items]	'	'	'	'	'	'	'	'	'	'
Trading Securities, Cost	'	'	'	'	'	'	1,207,335	'	'	'
Investments Level2 [Member]	'	'	'	'	'	'	'	'	'	'
Significant Accounting Policies [Line Items]	'	'	'	'	'	'	'	'	'	'
Available-for-sale Securities, Amortized Cost Basis, Total	'	'	'	'	'	'	$7,984,646	'	'	'

Property_and_Equipment_Details

Property and Equipment (Details) (USD $)	Aug. 31, 2013	Aug. 31, 2012
Gross property and equipment	$18,015,097	$19,544,457
Less accumulated depreciation and amortization	-11,691,440	-12,888,637
Net property and equipment	6,323,657	6,655,820
Land [Member]	'	'
Gross property and equipment	497,110	497,110
Buildings and improvements [Member]	'	'
Gross property and equipment	8,989,115	8,989,115
Equipment, furniture and fixtures [Member]	'	'
Gross property and equipment	$8,528,872	$10,058,232

Property_and_Equipment_Details1

Property and Equipment (Details Textual) (USD $)	12 Months Ended
	Aug. 31, 2013	Aug. 31, 2012
Property, Plant and Equipment [Line Items]	'	'
Depreciation expense	$463,552	$550,643
Property, Plant and Equipment, Gross, Including Capital Leased Assets	585,450	470,091
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Including Capital Leased Assets	$449,860	$340,461

Discontinued_Operations_Detail

Discontinued Operations (Details) (USD $)	12 Months Ended
	Aug. 31, 2013	Aug. 31, 2012
Income Statement Disclosures	'	'
Net patient service revenue	$451,965	$397,278
Costs and expenses:	'	'
Compensation and benefits	32,415	204,337
Medical services and supplies	-8,301	235,977
Other operating expenses	158,061	593,942
Asset impairment charge	0	1,058,056
Depreciation and amortization	0	82,353
Total costs and expenses	182,175	2,174,665
Operating income (loss)	269,790	-1,777,387
Other income (expense), net	4,600	382,403
Income (loss) before income taxes	274,390	-1,394,984
Benefit for income taxes	0	0
Income (loss) on discontinued operations, net of taxes	274,390	-1,394,984
Loss on disposal of discontinued assets	-122,975	-229,201
Benefit for income taxes	0	0
Loss on disposal of discontinued assets, net of income taxes	-122,975	-229,201
Total income (loss) on discontinued operations, net of taxes	151,415	-1,624,185
Balance Sheet Disclosures	'	'
Current assets	0	0
Property and equipment, net	0	5,401,092
Total assets	0	5,401,092
Current liabilities:	'	'
Accounts payable and accrued liabilities	0	0
Total liabilities	0	0
Garland Facility [Member]	'	'
Income Statement Disclosures	'	'
Net patient service revenue	451,965	397,278
Costs and expenses:	'	'
Compensation and benefits	32,415	181,693
Medical services and supplies	-8,301	235,977
Other operating expenses	158,061	957,090
Asset impairment charge	0	1,058,056
Depreciation and amortization	0	0
Total costs and expenses	182,175	2,432,816
Operating income (loss)	269,790	-2,035,538
Other income (expense), net	4,600	304,673
Income (loss) before income taxes	274,390	-1,730,865
Benefit for income taxes	0	0
Income (loss) on discontinued operations, net of taxes	274,390	-1,730,865
Loss on disposal of discontinued assets	-122,975	0
Benefit for income taxes	0	0
Loss on disposal of discontinued assets, net of income taxes	-122,975	0
Total income (loss) on discontinued operations, net of taxes	151,415	-1,730,865
Balance Sheet Disclosures	'	'
Current assets	0	0
Property and equipment, net	0	5,401,092
Total assets	0	5,401,092
Current liabilities:	'	'
Accounts payable and accrued liabilities	0	0
Total liabilities	0	0
China Operations [Member]	'	'
Income Statement Disclosures	'	'
Net patient service revenue	0	0
Costs and expenses:	'	'
Compensation and benefits	0	22,644
Medical services and supplies	0	0
Other operating expenses	0	-363,148
Asset impairment charge	0	0
Depreciation and amortization	0	82,353
Total costs and expenses	0	-258,151
Operating income (loss)	0	258,151
Other income (expense), net	0	77,730
Income (loss) before income taxes	0	335,881
Benefit for income taxes	0	0
Income (loss) on discontinued operations, net of taxes	0	335,881
Loss on disposal of discontinued assets	0	-229,201
Benefit for income taxes	0	0
Loss on disposal of discontinued assets, net of income taxes	0	-229,201
Total income (loss) on discontinued operations, net of taxes	0	106,680
Balance Sheet Disclosures	'	'
Current assets	0	0
Property and equipment, net	0	0
Total assets	0	0
Current liabilities:	'	'
Accounts payable and accrued liabilities	0	0
Total liabilities	$0	$0

Notes_Payable_Details

Notes Payable (Details) (USD $)	Aug. 31, 2013	Aug. 31, 2012
Debt Instrument [Line Items]	'	'
Total	$47,000	$1,179,922
Less: Current portion	-40,256	-105,735
Long-term portion	6,744	1,074,187
Apartment purchased in Hong Kong [Member]	'	'
Debt Instrument [Line Items]	'	'
Total	0	1,091,615
Equipment [Member]	'	'
Debt Instrument [Line Items]	'	'
Total	$47,000	$88,307

Notes_Payable_Details_Textual

Notes Payable (Details Textual) (USD $)	12 Months Ended
	Aug. 31, 2013	Aug. 31, 2012	Nov. 30, 2011	Sep. 30, 2010
Debt Instrument [Line Items]	'	'	'	'
Payments to Acquire Real Estate, Total	$2,014,207	'	'	'
Period Of Mortgage Loan	'18 years	'	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	1,245,775	'	'	'
Base Period To Be Considered For Variable Interest Rate	'3 months	'	'	'
Mortgage Loans on Real Estate, Minimum Interest Rate in Range	0.70%	'	'	'
Mortgage Loans on Real Estate, Maximum Interest Rate in Range	2.90%	'	'	'
Secured Debt	116,339	65,000	116,339	65,000
Debt Instrument, Interest Rate, Stated Percentage	4.50%	6.00%	'	'
Other Commitment, Due in Next Twelve Months	40,256	'	'	'
Other Commitment, Due in Second Year	$6,744	'	'	'

Income_Taxes_Details

Income Taxes (Details) (USD $)	12 Months Ended
	Aug. 31, 2013	Aug. 31, 2012
Current tax (benefit) expense:	'	'
Federal	$0	$0
State	0	0
Total current	0	0
Deferred tax (benefit) expense:	'	'
Federal	0	4,018,699
State	0	0
Total deferred	0	4,018,699
Total income tax expense	$0	$4,018,699

Income_Taxes_Details_1

Income Taxes (Details 1) (USD $)	12 Months Ended
	Aug. 31, 2013	Aug. 31, 2012
Applicable to:	'	'
Net operating loss carryforward	($1,611,973)	($4,941,754)
Differences between revenues and expenses recognized for federal income tax and financial reporting purposes	246,396	2,172,058
Difference in method of computing depreciation for tax and financial reporting purposes	26,981	49,061
Changes in valuation allowance	1,338,596	6,739,334
Deferred income tax expense	$0	$4,018,699

Income_Taxes_Details_2

Income Taxes (Details 2) (USD $)	Aug. 31, 2013	Aug. 31, 2012
Deferred tax liabilities:	'	'
Depreciation, Noncurrent	($207,396)	($180,415)
Deferred tax assets:	'	'
Net operating loss carryforward, Noncurrent	9,439,548	7,827,575
Revenue and expense differences, Current	13,157	54,664
Revenue and expense differences, Noncurrent	3,580,862	3,342,010
Allowance for uncollectible accounts, Current	513,456	513,456
Asset impairment, Current	'	370,320
Asset impairment, Non-current	'	0
Other, Current	-166,758	-166,758
Other, Noncurrent	-29,869	43,551
Valuation allowance, Current	-359,855	-771,682
Valuation allowance, Noncurrent	-12,783,145	-11,032,721
Net deferred tax asset (liability), Current	0	0
Net deferred tax asset (liability), Noncurrent	$0	$0

Income_Taxes_Details_3

Income Taxes (Details 3) (USD $)	12 Months Ended
	Aug. 31, 2013	Aug. 31, 2012
Income Tax [Line Items]	'	'
Benefit for income taxes computed using the statutory rate of 35%	($1,210,767)	($2,294,590)
Noncontrolling interest in loss of consolidated subsidiaries	993	16,575
Non-deductible expenses	-128,822	-442,620
Changes in valuation allowance	1,338,596	6,739,334
Expense for income taxes	$0	$4,018,699

Income_Taxes_Details_Textual

Income Taxes (Details Textual) (USD $)	12 Months Ended
	Aug. 31, 2013	Aug. 31, 2012
Income Tax [Line Items]	'	'
Income Tax Expense Benefit	$0	$4,018,699
Percentage Of Likeli hood To Be Realized Upon Settlement	50.00%	'
Deferred Tax Assets, Operating Loss Carryforwards, Domestic	$27,000,000	'
Operating Loss Carryforwards Expiration Period	'2031 through 2033	'

Related_Party_Transactions_Det

Related Party Transactions (Details Textual) (USD $)	12 Months Ended
	Aug. 31, 2013	Aug. 31, 2012	Aug. 31, 2009
Related Party Transaction [Line Items]	'	'	'
Related Party Transaction Hourly Rate For Physicians	$75	'	'
Related Party Transaction Payment Made For Emergency Room Physician Services	397,050	421,725	'
Due from Affiliates	0	46,848	'
Accrued Liabilities Current	11,845,317	11,763,362	'
Former Chief Executive Officer [Member]	'	'	'
Related Party Transaction [Line Items]	'	'	'
Accrued Liabilities Current	231,333	270,468	'
Anesthesia Associates [Member]	'	'	'
Related Party Transaction [Line Items]	'	'	'
Related Party Transaction, Expenses from Transactions with Related Party	'	'	5,000
Related Party Transaction Payment Made To Related Party	60,000	60,000	'
Redwood [Member]	'	'	'
Related Party Transaction [Line Items]	'	'	'
Related Party Transaction Rent And Management Fees Received From Related Party	3,831	14,938	'
Related Party Transaction, Expenses from Transactions with Related Party	'	'	20,000
Payment For Recruitment Services	$240,000	$240,000	'

Stockholders_Equity_and_Stock_2

Stockholders' Equity and Stock Option Plan (Details) (USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Aug. 31, 2013	Aug. 31, 2012
Stock Option Activities [Line Items]	'	'
Shares Outstanding, Beginning balance	2,791	2,206
Stock options granted	0	1,450
Shares, Exercised	0	0
Shares, Expired or canceled	-1,694	-865
Shares Outstanding, Ending balance	1,097	2,791
Weighted Average Option Exercise Price Per Share Outstanding, Beginning balance	$1.92	$2.41
Weighted Average Option Exercise Price Per Share, Granted	$0	$1.03
Weighted Average Option Exercise Price Per Share, Exercised	$0	$0
Weighted Average Option Exercise Price Per Share, Expired or cancelled	$1.74	$1.68
Weighted Average Option Exercise Price Per Share, Ending balance	$2.21	$1.92

Stockholders_Equity_and_Stock_3

Stockholders' Equity and Stock Option Plan (Details 1) (USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Aug. 31, 2013
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]	'
Options Outstanding, Shares	1,097
Options Outstanding, Weighted Average Remaining Contractual Life (Years)	'6 years 9 months 18 days
Options Exercisable, Shares	580
Range One [Member]	'
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]	'
Range of Exercise Prices, Range Limit	1.1
Options Outstanding, Shares	250
Options Outstanding, Weighted Average Remaining Contractual Life (Years)	'8 years 4 months 24 days
Options Exercisable, Shares	63
Range Two [Member]	'
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]	'
Range of Exercise Prices, Range Limit	1.86
Options Outstanding, Shares	660
Options Outstanding, Weighted Average Remaining Contractual Life (Years)	'7 years 10 months 24 days
Options Exercisable, Shares	330
Range Three [Member]	'
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]	'
Range of Exercise Prices, Range Limit	4.9
Options Outstanding, Shares	187
Options Outstanding, Weighted Average Remaining Contractual Life (Years)	'1 year 3 months 18 days
Options Exercisable, Shares	187

Stockholders_Equity_and_Stock_4

Stockholders' Equity and Stock Option Plan (Details 2) (USD $)	12 Months Ended
	Aug. 31, 2012
Weighted Average Assumptions [Line Items]	'
Estimated fair value per share	$0.52
Expected life (years)	'4 years 1 month 6 days
Risk free interest rate	0.79%
Volatility	78.00%
Dividend yield	0.00%

Stockholders_Equity_and_Stock_5

Stockholders' Equity and Stock Option Plan (Details Textual) (USD $)	12 Months Ended				0 Months Ended					12 Months Ended
	Aug. 31, 2013	Aug. 31, 2012	Sep. 30, 2010	Aug. 31, 2013	Feb. 06, 2012	Jan. 12, 2012	Nov. 14, 2011	Aug. 31, 2013	Aug. 31, 2011	Aug. 31, 2013
				Stock Option [Member]	Year 2011 Stock Incentive Plan [Member]	Year 2011 Stock Incentive Plan [Member]	Year 2011 Stock Incentive Plan [Member]	Year 2011 Stock Incentive Plan [Member]	Year 2011 Stock Incentive Plan [Member]	Year 2000 Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'	'	'	'	'	'	'
Preferred Stock Shares Authorized	5,000,000	5,000,000	'	'	'	'	'	'	'	'
Common stock shares reserved	'	'	'	'	'	'	'	'	15,000,000	5,000,000
Stock options granted	0	1,450,000	'	'	'	250,000	200,000	'	'	'
Weighted average option exercise price per share	$0	$0	'	'	$1	$1.10	$1.07	'	'	'
Stock options vested in annual installments beginning on the first anniversary date	'	'	'	'	'	25.00%	'	'	'	'
Shares to be issued upon exercise of outstanding options	'	'	'	'	'	'	'	250,000	'	846,475
Shares to be issued under after giving effect to shares issued and canceled	'	'	'	'	'	'	'	14,750,000	'	'
New stock option awards issued	'	'	'	'	'	'	'	'	'	0
Stock-based compensation expense associated with the Company's stock options	$109,462	$325,408	'	'	'	'	'	'	'	'
Total unrecognized compensation expense for outstanding stock options	'	'	'	378,000	'	'	'	'	'	'
Employee service share based compensation nonvested stock options compensation cost not yet recognized period	'1 year 10 months 24 days	'	'	'	'	'	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value	0	'	0	'	'	'	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value	'	$754,224	'	'	'	'	'	'	'	'

Employee_Benefit_Plan_Details_

Employee Benefit Plan (Details Textual) (USD $)	12 Months Ended
	Aug. 31, 2013	Aug. 31, 2012
Company's Contributions to plan	$29,092	$32,322

Net_Income_Loss_Per_Share_Deta

Net Income (Loss) Per Share (Details) (USD $)	12 Months Ended
	Aug. 31, 2013	Aug. 31, 2012
Numerator:	'	'
Loss from continuing operations	($3,459,335)	($10,574,669)
Less: Net loss attributable to noncontrolling interest	2,836	47,358
Loss from continuing operations attributable to Dynacq Healthcare, Inc.	-3,456,499	-10,527,311
Income (loss) from discontinued operations, net of income taxes	151,415	-1,624,185
Net loss attributable to Dynacq Healthcare, Inc.	($3,305,084)	($12,151,496)
Denominator:	'	'
Basic and diluted average common shares outstanding	14,543,626	14,489,780
Basic and diluted earnings (loss) per common share:	'	'
Loss from continuing operations attributable to Dynacq Healthcare, Inc.	($0.24)	($0.73)
Income (loss) from discontinued operations, net of income taxes	$0.01	($0.12)
Net loss attributable to Dynacq Healthcare, Inc.	($0.23)	($0.85)

Net_Income_Loss_Per_Share_Deta1

Net Income (Loss) Per Share (Details Textual) (Employee Stock Option [Member])	12 Months Ended
	Aug. 31, 2013	Aug. 31, 2012
Employee Stock Option [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Stock options with exercise prices exceeding current market prices	1,096,475	2,790,566

Other_Comprehensive_Income_Los2

Other Comprehensive Income (Loss) and Accumulated Other Comprehensive Income (Details) (USD $)	12 Months Ended
	Aug. 31, 2013	Aug. 31, 2012
Components Of Other Comprehensive Income Loss [Line Items]	'	'
Change in Foreign Currency Translation Adjustment, Beginning Balance	$8,196	'
Other comprehensive income before reclassifications, Change in Foreign Currency Translation Adjustment	0	-23,268
Amounts reclassified from accumulated other comprehensive income, Change in Foreign Currency Translation Adjustment	-8,196	-921,318
Net current-period other comprehensive income (loss), Change in Foreign Currency Translation Adjustment	-8,196	-944,586
Change in Foreign Currency Translation Adjustment, Ending Balance	0	8,196
Change in Fair Value of Available for Sale Securities, Beginning Balance	8,411,128	'
Other comprehensive income before reclassifications, Change in Fair Value of Available for Sale Securities	3,170,706	'
Amounts reclassified from accumulated other comprehensive income, Change in Fair Value of Available for Sale Securities	-2,199,500	'
Net current-period other comprehensive income (loss), Change in Fair Value of Available for Sale Securities	971,206	1,910,234
Change in Fair Value of Available for Sale Securities, Ending Balance	9,382,334	8,411,128
Accumulated Other Comprehensive Income (Loss), Beginning Balance	8,419,324	'
Other comprehensive income before reclassifications, Accumulated Other Comprehensive Income (Loss)	3,170,706	'
Amounts reclassified from accumulated other comprehensive income, Accumulated Other Comprehensive Income (Loss)	-2,207,696	'
Net current-period other comprehensive income (loss) , Accumulated Other Comprehensive Income (Loss)	963,010	965,648
Accumulated Other Comprehensive Income (Loss), Ending Balance	$9,382,334	$8,419,324

Other_Comprehensive_Income_Los3

Other Comprehensive Income (Loss) and Accumulated Other Comprehensive Income (Details 1) (USD $)	12 Months Ended
	Aug. 31, 2013	Aug. 31, 2012
Schedule Of Reclassification Out Of Accumulated Other Comprehensive Income [Line Items]	'	'
Gain on foreign currency translation adjustment	$12,610	'
Tax provision	-4,414	-501,273
Amounts reclassified from accumulated other comprehensive income	8,196	921,318
Gain on call of available for sale securities	2,199,500	'
Tax provision	0	'
Amounts reclassified from accumulated other comprehensive income change in Fair value of Available for sale securities	$2,199,500	'

Other_Comprehensive_Income_Los4

Other Comprehensive Income (Loss) and Accumulated Other Comprehensive Income (Details 2) (USD $)	Aug. 31, 2013	Aug. 31, 2012
Foreign currency translation adjustment, net of taxes of $-0- and $4,414, respectively	$0	$8,196
Change in valuation of investment available-for-sale, net of taxes of $-0- and $-0-, respectively	9,382,334	8,411,128
Total accumulated other comprehensive income, net of taxes of $-0- and $4,414, respectively	$9,382,334	$8,419,324

Other_Comprehensive_Income_Los5

Other Comprehensive Income (Loss) and Accumulated Other Comprehensive Income (Details Textual) (USD $)	12 Months Ended
	Aug. 31, 2013	Aug. 31, 2012
Schedule of Other Comprehensive Income Loss and Accumulated Other Comprehensive Income [Line Items]	'	'
Foreign currency translation adjustment, taxes	($4,414)	($513,803)
Change in valuation of investment available-for-sale, net of taxes	0	0
Total accumulated other comprehensive income, net of taxes	$0	$4,414

Accrued_Liabilities_Details

Accrued Liabilities (Details) (USD $)	Aug. 31, 2013	Aug. 31, 2012
Accrued Liabilities [Line Items]	'	'
MDR stop-loss cases accrual, including accrued interest	$10,231,033	$9,548,602
Marketing fees liability	300,000	300,000
Payroll and related taxes	306,450	389,713
Property taxes	189,202	339,527
Year-end accruals of expenses and other	818,632	1,185,520
Total accrued liabilities	$11,845,317	$11,763,362

Commitments_and_Contingencies_

Commitments and Contingencies (Details Textuals) (USD $)	1 Months Ended	12 Months Ended
	Dec. 27, 2012	Aug. 31, 2013	Aug. 31, 2012
Schedule Of Commitments and Contingencies [Line Items]	'	'	'
Operating Leases, Rent Expense	'	$131,000	$127,000
Interest Payable	'	8,100,000	'
Additional Interest Payable Current And Noncurrent	'	2,200,000	'
Other Commitment, Due in Second Year	'	6,744	'
Other Commitment, Due in Next Twelve Months	'	40,256	'
Capital Leases, Future Minimum Payments, Due in Rolling Year Four	'	11,000	'
Aggregate Commitment Amount	'	12,200,000	'
Aggregate Commitment Amount Due In Next Twelve Months	'	11,800,000	'
Aggregate Commitment Amount Due In second year	'	113,000	'
Aggregate Commitment Amount Due In Third year	'	99,000	'
Aggregate Commitment Amount Due In Four Year	'	69,000	'
Aggregate Commitment Amount Due In Five year	'	58,000	'
Debt Instrument, Interest Rate, Effective Percentage	'	4.50%	'
Property Plant And Equipment Amount Secured By Notes Payable	'	48,000	'
Property Plant And Equipment Amount Secured By Notes Payable In Next Twelve Months	'	41,000	'
Property Plant And Equipment Amount Secured By Notes Payable In Year Two	'	7,000	'
Operating Leases, Future Minimum Payments Due, Next Twelve Months	'	70,000	'
Operating Leases, Future Minimum Payments, Due in Two Years	'	68,000	'
Operating Leases, Future Minimum Payments, Due in Three Years	'	64,000	'
Operating Leases, Future Minimum Payments, Due in Four Years	'	58,000	'
Operating Leases, Future Minimum Payments, Due in Five Years	'	58,000	'
Operating Leases, Future Minimum Payments Due, Total	'	318,000	'
Investigation Cost	2,000,000	'	'
Other Cost And Expense Operating	'	5,956,192	4,399,283
Third Parties [Member]	'	'	'
Schedule Of Commitments and Contingencies [Line Items]	'	'	'
Other Cost And Expense Operating	'	7,800,000	'
Service Agreements [Member]	'	'	'
Schedule Of Commitments and Contingencies [Line Items]	'	'	'
Commitments To Complete Contracts	'	1,156,000	1,190,000
Other Commitment, Due in Second Year	'	793,000	'
Administrative Support Services [Member]	'	'	'
Schedule Of Commitments and Contingencies [Line Items]	'	'	'
Other Commitment, Due in Second Year	'	6,000	'
Payments Made Under Agreements	'	440,000	266,000
Other Commitment, Total	'	272,000	'
Other Commitment, Due in Next Twelve Months	'	263,000	'
Other Commitment, Due in Third Year	'	$3,000	'

Concentrations_of_Credit_Risk_2

Concentrations of Credit Risk and Fair Value of Financial Instruments (Details)	12 Months Ended
	Aug. 31, 2013	Aug. 31, 2012
Concentration Risk [Line Items]	'	'
Concentration Risk, Percentage	100.00%	100.00%
Third-Party Payor [Member] | Other Credit Derivatives [Member]	'	'
Concentration Risk [Line Items]	'	'
Concentration Risk, Percentage	3.00%	4.00%
Third-Party Payor [Member] | Workers' compensation [Member]	'	'
Concentration Risk [Line Items]	'	'
Concentration Risk, Percentage	11.00%	11.00%
Third-Party Payor [Member] | Commercial [Member]	'	'
Concentration Risk [Line Items]	'	'
Concentration Risk, Percentage	43.00%	40.00%
Self-Pay [Member]	'	'
Concentration Risk [Line Items]	'	'
Concentration Risk, Percentage	14.00%	16.00%
Accounts Receivable [Member] | Credit Concentration Risk [Member] | Third-Party Payor [Member] | Other Credit Derivatives [Member]	'	'
Concentration Risk [Line Items]	'	'
Concentration Risk, Percentage	1.00%	1.00%
Accounts Receivable [Member] | Credit Concentration Risk [Member] | Third-Party Payor [Member] | Workers' compensation [Member]	'	'
Concentration Risk [Line Items]	'	'
Concentration Risk, Percentage	1.00%	1.00%
Accounts Receivable [Member] | Credit Concentration Risk [Member] | Third-Party Payor [Member] | Workers' compensation subject to Medical Dispute Resolution process [Member]	'	'
Concentration Risk [Line Items]	'	'
Concentration Risk, Percentage	84.00%	84.00%
Accounts Receivable [Member] | Credit Concentration Risk [Member] | Third-Party Payor [Member] | Commercial [Member]	'	'
Concentration Risk [Line Items]	'	'
Concentration Risk, Percentage	9.00%	9.00%
Accounts Receivable [Member] | Credit Concentration Risk [Member] | Third-Party Payor [Member] | Medicare Government [Member]	'	'
Concentration Risk [Line Items]	'	'
Concentration Risk, Percentage	1.00%	1.00%
Accounts Receivable [Member] | Credit Concentration Risk [Member] | Self-Pay [Member]	'	'
Concentration Risk [Line Items]	'	'
Concentration Risk, Percentage	4.00%	4.00%

Concentrations_of_Credit_Risk_3

Concentrations of Credit Risk and Fair Value of Financial Instruments (Details Textual) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Aug. 31, 2013	Aug. 31, 2012
Concentration Risk [Line Items]	'	'
Concentration Risk, Percentage	100.00%	100.00%
Concentrations Of Credit Risk And Fair Value Of Financial Instruments Textual [Abstract]	'	'
Cash, Uninsured Amount	$11.90	'
Percentage Of Third Party Gross Receivables	90.00%	'
Credit Concentration Risk [Member] | Major Customers One [Member] | Revenue [Member]	'	'
Concentration Risk [Line Items]	'	'
Concentration Risk, Percentage	22.00%	'
Customer Concentration Risk [Member] | US Discontinued Operations [Member] | Revenue [Member]	'	'
Concentration Risk [Line Items]	'	'
Concentration Risk, Percentage	'	25.00%
Customer Concentration Risk [Member] | China Discontinued Operations [Member] | Revenue [Member]	'	'
Concentration Risk [Line Items]	'	'
Concentration Risk, Percentage	'	10.00%
Customer Concentration Risk [Member] | Major Customers Two [Member] | Revenue [Member]	'	'
Concentration Risk [Line Items]	'	'
Concentration Risk, Percentage	11.00%	'
Customer Concentration Risk [Member] | Major Customers Three [Member] | Revenue [Member]	'	'
Concentration Risk [Line Items]	'	'
Concentration Risk, Percentage	11.00%	'
Accounts Receivable [Member] | Credit Concentration Risk [Member] | Third Party Payor One [Member]	'	'
Concentration Risk [Line Items]	'	'
Concentration Risk, Percentage	16.00%	14.00%
5 Surgeons [Member] | Customer Concentration Risk [Member] | Revenue [Member]	'	'
Concentration Risk [Line Items]	'	'
Concentration Risk, Percentage	90.00%	'
7 Surgeons [Member] | Customer Concentration Risk [Member] | Revenue [Member]	'	'
Concentration Risk [Line Items]	'	'
Concentration Risk, Percentage	'	90.00%

Industry_Segments_and_Geograph2

Industry Segments and Geographic Information (Details) (USD $)	12 Months Ended
	Aug. 31, 2013	Aug. 31, 2012
Segment Reporting Information [Line Items]	'	'
Net patient service revenues	$6,057,411	$5,531,233
Loss before taxes and discontinued operations	-3,459,335	-6,555,970
US Division [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Net patient service revenues	6,057,411	5,531,233
Loss before taxes and discontinued operations	-3,070,917	-4,040,738
Corporate [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Net patient service revenues	0	0
Loss before taxes and discontinued operations	($388,418)	($2,515,232)

Industry_Segments_and_Geograph3

Industry Segments and Geographic Information (Details 1) (USD $)	Aug. 31, 2013	Aug. 31, 2012
Segment Reporting Information [Line Items]	'	'
Total Assets	$41,636,327	$46,185,296
Assets of continuing operations [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Total Assets	41,636,327	40,784,204
Assets of discontinued operations [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Total Assets	0	5,401,092
US Division [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Total Assets	9,924,501	8,072,893
Corporate [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Total Assets	$31,711,826	$32,711,311

Industry_Segments_and_Geograph4

Industry Segments and Geographic Information (Details Textual) (USD $)	12 Months Ended
	Aug. 31, 2013	Aug. 31, 2012
Segment Reporting Information [Line Items]	'	'
Impairment charge	'	$1,100,000
Gain from marketable securities	2,200,000	'
Balance from marketable securities	17,458,985	16,828,886
Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax	-122,975	-229,201
Hong Kong [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Gain (Loss) on the initial public offerings of equity securities	$695,008	($318,206)